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STUDY ON COLONOSCOPIC FINDINGS IN POSITIVE FAECAL 
OCCULT BLOOD TESTING  
INTRODUCTION 
        Colorectal cancer is the third most common cancer in the world and a leading 
cause of cancer death in the Western world. There is an increase in incidence of 
colorectal carcinoma in India due to,economic shift from low income to middle 
income economy  and increase in ageing population, life style and dietary factors. 
AIMS OF STUDY 
 To  study  colonoscopic  findings in positive faecal occult blood  test             
patients 
 To study other screening modalities in colorectal carcinoma 
MATERIALS AND METHODS 
       Patients admitted in various surgical units in thanjavur medical college 
hospital between January 2013  to july 2014  constitute the materials of this study. 
The exclusion criteria includes  patients with complaints of bleeding PR, altered 
bowel habits , tenesmus , mucus discharge from PR, spurious diarrhea ,mass 
desending PR ,FOBT within last one year, sigmoidoscopy within last 3 to 5 years, 
colonoscopy within last 10 years. 
The inclusion criteria includes patients with age of 50 and above, patients willing 
for further followup ( invasive procedures like colonoscopy&UGI scopy) 
A total  of 200  patients were studied, patients with positive faecal occult blood test 
are included in this study, those who are negative for FOBT were  adviced  for 
follow up, one year later for another FOBT test.  
RESULT 
Only 52 patients were positive for FOBT out of 200 patients. In FOBT positive 
patients 12 patients are not willing for colonoscopy,40 patients went through 
colonoscopy .Of them, 6 had haemorrhoids, 1 had a polyp and a carcinoma each 
and one other patient had diverticulum rest of patients have normal colonoscopy. 
CONCLUSION: 
 Faecal  occult blood test screening offers no benefit without appropriate 
follow up diagnostic tests and treatment. 
 It is simple, safe and cost effective but is limited by lack of acceptability, 
compliance and adherence as well as poor sensitivity and specificity. 
 In considering all the advantages and drawbacks of FOBT in colorectal 
cancer screening, we can conclude that this examination is certainly better 
than no testing at all. 
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                                       INTRODUCTION 
 
Colorectal cancer is the third most common cancer in the world and a 
leading cause of cancer death in the Western world. The life time risk of 
colorectal carcinoma was 6%-7%, incidence rate increases after the age of 50. 
.In India incidence rate in male-4.3/1,00,000 and female-3.4/1,00,000 ,Highest 
in korea-male-46/100000,female-25/100000.Datas  from  rural population based 
registries,  shows  incidence rate of colon cancer was very low  in rural setting 
but incidence rate  was disproportionately more in rural India . 
Colorectal carcinogenesis is exceptionally suited for screening, since the 
adenoma–carcinoma sequence used in detection and removal of pre-cancerous 
lesions, and   it is well established that patients who are maintained free of 
polypoidal adenoma by endoscopic polypectomy are generally kept cancer free. 
There is an increase in incidence of colorectal carcinoma in India due to,                                                            
 Economic shift from low income to middle income economy  and                
increase in ageing population, 
 life style and dietary factors, 
 Increased use of screening modalities. 
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      AIM OF STUDY 
 
 To  study  colonoscopic  findings in positive faecal occult blood  test 
patients 
 To study effectiveness of faecal occult blood test in colorectal carcinoma 
screening 
 To study factors that affect low uptake of faecal occult blood test 
 To study other screening modalities in colorectal carcinoma 
 To study various treatment modalities and recent trends  in colorectal 
carcinoma 
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REVIEW OF LITERATURE 
 
EMBRYOLOGY 
The caecum, ascending colon, and proximal third of the transverse colon 
are derived from the midgut. The rest of the large bowel, rectum, and upper part 
of the anal canal develops from the hindgut. The caecal swelling is the last part 
of the midgut to reenter the abdominal cavity. The caecal bud is originally 
present in the right upper quadrant, where it forms the caecum and the appendix 
and subsequently descends into the right iliac fossa, thereby forming the 
ascending colon and the hepatic flexure. Once the colon has reached its 
definitive position, the mesenteries of the ascending and descending colons fuse 
with the posterior abdominal wall, thus rendering them retroperitoneal 
structures. The transverse colon and the sigmoid colon retain their mesentery. 
During the early developmental stage, the appendix is the caudal 
extension of the caecum and possesses the same caliber. The right wall of the 
caecum grows rapidly downward and begins to displace the appendix medially 
and closer to the ileocecal area. 
The rectum and the proximal part of the anal canal (i.e., to the level of the 
pectinate line) are derived from the hindgut. The distal segment of the anal 
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canal develops from the proctoderm. The expanded lower part of the hindgut, 
known as the  cloaca, is in direct contact with the surface ectoderm, the cloacal 
membrane. The allantois, which is a diverticulum of the yolk sac, opens on the 
ventral aspect of the cloaca. A sheet of mesenchymal tissue known as the 
urorectal septum grows caudally between the allantois and the cloaca and 
partitions the cloaca into an anterior portion, the primitive urogenital sinus, and 
a posterior part, the anorectal canal. The urorectal septum continues to grow 
caudally and fuses with the cloacal membrane, and this area of fusion represents 
the perineal body in adults. This fusion creates the anterior urogenital 
membrane and the posterior anorectal membrane. The blood supply of the anus 
can be explained by the different embryologic origins of its superior and 
inferior segments. The upper two thirds of the anal canal is derived from the 
endoderm and is therefore supplied by the artery of the hindgut, the inferior 
mesenteric artery, whereas the distal third of the anus is ectodermal in origin 
and is supplied by branches of the internal iliac artery. 
ANATOMY 
The large intestine extends from the ileocecal junction to the anal orifice and 
measures approximately 103 cm long. It can be distinguished from the small 
bowel by the following features: 
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 (1) Presence of teniae, which are three bands of longitudinal muscle; 
 (2) The appendices epiploicae, which are fatty appendages projecting from the 
serosal surface of the bowel; and 
 (3) The haustra, which are sacculations caused by the longitudinal muscle‘s 
being shorter than the rest of the bowel wall. 
  The components of large intestine include the cecum, appendix, ascending 
colon, transverse colon, descending colon, sigmoid colon, rectum, and anal 
canal.  
Cecum 
The cecum is a dilated pouch measuring about 6 to 8 cm, below the level 
of the ileocecal valve. It is situated in the right lower quadrant lying on the 
iliacus and psoas muscles. It is completely invested with peritoneum, which 
allows it to be mobile. The three teniae of the cecum converge on the 
posteromedial aspect at the base of the appendix. The tip of the appendix is 
often lying in the pelvis but can also be found behind the cecum  (retrocecal 
fossa). The ileocecal valve is an oval opening that is present on the medial 
aspect of the cecum. The circular muscle of the distal ileum acts as the 
sphincter. The arterial blood supply of the cecum is derived from anterior and 
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posterior cecal arteries, which are branches of the ileocolic artery. The venous 
drainage corresponds to the arterial supply and drains into the superior 
mesenteric vein. The lymphatic drainage is via nodes that follow the vessels. 
Appendix  
The appendix varies in length from 8 to 14 cm and arises from the 
posteromedial surface of the cecum, where all three taeniae coli meet. The 
position of the appendix can vary considerably among patients. It can be located 
in the pelvis, behind or along the lateral border of the cecum, or anterior or 
posterior to the distal ileum. The appendix possesses a complete peritoneal 
covering and has its own mesoappendix, which is attached to the mesentery of 
the distal ileum. Contained within the mesoappendix is the appendicular artery, 
which is a branch of the posterior cecal artery. Venous drainage of the appendix 
is via the appendicular vein, which drains into the posterior cecal vein. The 
nerve supply of the appendix is derived from both sympathetic and vagal fibers. 
Visceral pain from the appendix is conducted by the afferent sympathetic fibers 
that enter at the T10 spinal level. 
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Ascending Colon 
The ascending colon (15 to 20 cm long) extends upward from the cecum 
and turns sharply to the left to form the hepatic flexure and then becomes 
continuous with the transverse colon. The peritoneum lines the anterior and 
lateral surfaces of the ascending colon, whereas the posterior surface lies 
against the posterior abdominal wall. Lateral to the ascending colon is the 
paracolic gutter, which leads to the subphrenic space superiorly. Posteriorly it 
lies on the iliacus, quadrates lumborum, and lower pole of the right kidney. It 
receives its arterial blood supply from the ileocolic and the right colic branches 
of the superior mesenteric artery. The veins correspond to the arteries and drain 
into the superior mesenteric vein. Lymphatic drainage is into nodes that lie 
along the above-named blood vessels 
Transverse Colon 
The transverse colon measures approximately 50 cm long and extends 
upward from the hepatic flexure to the left to form the splenic flexure, which is 
suspended from the diaphragm by the phrenicocolic ligament. It is attached by 
the transverse mesocolon to the anterior border of the pancreas on the posterior 
abdominal wall. The anterior leaf of the transverse mesocolon adheres to the 
greater omentum. Posteriorly the colon is related to the second part of 
15 
 
duodenum, head of the pancreas, loops of small bowel, and left kidney. Owing 
to the dual embryologic origin, the proximal two thirds of the transverse colon 
receives its blood supply from the middle colic artery, which runs within the 
transverse mesocolon and is the second branch of the superior mesenteric 
artery. The left colic artery, a branch of the inferior mesen-teric artery, supplies 
the distal one third of the transverse colon. The veins correspond to the arteries 
and drain into the superior and inferior mesenteric veins. The lymphatic 
drainage follows the colic blood supply. 
Descending Colon 
This segment of the colon is the narrowest and measures approximately 
30 cm. It extends downward in the left lumbar region from the splenic flexure 
to the pelvic brim, where it continues as the sigmoid colon. Similar to the 
ascending colon, the peritoneum covers the anterolateral wall and forms the left 
paracolic gutter. Thus, the posterior surface of the descending colon is a 
retroperitoneal structure. Posterior relations include the lower pole of the left 
kidney, diaphragm, quadrates lumborum, iliacus, and psoas muscles. The 
arterial blood supply is derived from the left colic branch of the inferior 
mesenteric artery. The vein corresponds to the artery and drains into the inferior 
mesenteric vein. The lymphatic drainage follows the colic blood vessels. 
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Sigmoid Colon 
This segment of the colon measures approximately 40 cm and extends 
from the pelvic brim to the third sacral vertebra. It is suspended by a V-shaped 
sigmoid mesocolon, the apex of which is situated over the left ureter where it 
crosses the pelvic brim. The left limb of the V is attached along the medial 
aspect of the external iliac artery, and the right limb runs from the bifurcation of 
the left common iliac artery downward to the third sacral vertebra. The arterial 
blood supply of the sigmoid colon is derived from sigmoid branches of the 
inferior mesenteric artery, and the venous drainage is into the inferior 
mesenteric vein. Lymph drainage is into nodes along the inferior left colic 
artery and subsequently to the inferior mesenteric nodes. 
Rectum  
The rectum extends from the sigmoid colon to the anal canal. It measures 
approximately 12 to 13 cm and begins in front of the first sacral vertebra and 
follows the hollow of the sacrum to end at the level of the tip of the coccyx. 
When viewed in the coronal view, the rectum deviates initially to the left and 
then returns to the midline. In the sagittal plane the rectum can be seen 
following the concavity of the sacrum and inferiorly widens to form the rectal 
ampulla and then passes downward and posteriorly to join the anal canal. The 
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rectum does not have a mesentery, but the peritoneum covers the lateral and 
anterior surfaces of the upper third of the rectum; only the anterior surface of 
the middle third and the lower third has no peritoneal covering. 
Several fasciae of the rectum are of surgical importance. The visceral pelvic 
fascia (also known as rectal fascia propria) surrounds the mesorectum 
posteriorly. This fascial envelope encloses fat, blood vessels, nerves, and 
lymphatics of the rectum. Between the rectal fascia propria and the parietal 
(presacral) fascia is loose areolar tissue that is the plane of dissection when 
performing total mesorectal excision. The parietal fascia, which lines the pelvic 
walls, is known as the presacral fascia in the region of the sacrum. The 
presacral fascia is tightly adherent to concavity of the sacral periosteum, 
especially in the midline and around the anterior sacral foramina. The presacral 
fascia protects the presacral veins and the hypogastric plexus lying beneath it. 
The fascia of Waldeyer is a more membranous portion of the pelvic fascia that 
extends from the sacrum to the rectal ampulla. Just above the pelvic floor there 
is condensation of areolar tissue around the middle rectal vessels known as the 
lateral ligament of the rectum. Anteriorly, the Denonvilliers‘ fascia is adherent 
to the fascia propria of the rectum. 
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The blood supply of the rectum is from  
   
•     The superior rectal artery, which is a terminal branch of the inferior 
mesenteric artery 
   •     The middle rectal artery, which is a branch of the internal iliac artery 
   
•     The inferior rectal artery, which is a branch of the internal pudendal 
artery 
The venous drainage of the rectum follows that of the arteries,  
 superior rectal vein draining into the portal circulation 
 the middle and inferior rectal veins drain into the systemic circulation. 
  The free communications between the rectal veins form an important 
portosystemic anastomosis. 
 The lymphatic drainage of the rectum is via lymphatics that travel along with 
the superior, middle, and inferior rectal arteries 
     rectouterine or rectovesical pouch: 
          Inferiorly rectum and surrounding tissue are separated by denonviller‘s 
fascia in the anterior part.posterior rectum and mesorectum are covered by 
waldeyer‘sfascia. Circumferential areolar tissue below the peritoneum 
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reflection which carries blood supply and lymphatic drainage is known as 
mesorectum. 
 
lymphatic drainage: 
             Lymphatic drainage is extensive comprise of epicolic nodes adjacent to 
colon. paracolic nodes alone the marginal vessels which form tier 1 and 2 nodes, 
Intermediate nodes along larger arteries and fourth tier nodes along and superior 
and inferior mesenteric artery which form the principle nodes .when tier 4 nodes 
are involved the disease is incurable. Rectum majority drain along inferior 
mesenteric artery .Lower rectum drains laterally along the middle and inferior 
rectal artery to internal iliac nodes. 
nerve supply: 
            Sympathetic- Hypogastric nerve from hypogastric plexus. Parasympathetic-
nervi erigentes from pelvic plexus. Preservation of autonomic nerves important 
during surgery to prevent impotence. 
 
  histology 
  Wall of colon comprises 
        Mucosa –surface epithelim [columnar] Lamina propria Muscularis mucosa  
            Submucosa 
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            Muscular layer 
            Sub serosa 
            Serosa 
physiology of colon:  
      About 1000ml of ileal contents containing 90% water are discharged into 
the caecum of which only 100-200ml of water is excreted in faeces. Normal 
faeces are composed of 70% water and 30% solids are bacteria. Nutrient such 
as glucose, aminoacids, fatty acids and vitamins can be absorbed slowly 
through the colonic wall. Sodium absorption is very efficient. Pottasium is 
actively excreted frequency of bowel movements ranges from once in 8 hrs to 
once in 2-3 days. 
Motility  
Motor activity of the colon occurs in three patterns, and there is marked 
regional variation between the right and left colon. A pacemaker in the 
transverse colon has been postulated, perhaps pacing the proximal colon 
retrograde to facilitate storage and absorption while pacing the distal colon in 
the anterograde  to favor propulsion. Retrograde peristalsis (antiperistalsis)—
annular contractions moving orad—dominates in the right colon. This kind of 
activity churns the contents and tends to confine them to the cecum and 
ascending colon. As ileal effluent continually enters the cecum, some of the 
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column of liquid stool in the right colon is displaced and flows into the 
transverse colon. Segmentation is the most common type of motor activity in 
the transverse and descending colon. Annular contractions divide the lumen into 
uniform segments, propelling feces over short distances in both directions. 
Mass movement is a strong ring contraction   moving aborad over long 
distances in the transverse and descending colon. It occurs infrequently—
perhaps only a few times daily—most commonly after meals. 
gastro colic reflex: 
It refers to increased ileal emptying, increased mass movements and urge to 
defecate on eating. In general residue from meal reaches caecum after 4 hrs and 
rectosigmoid by 24 hrs. 
 
microbiology of colon: 
Microbes exist in symbiotic relationship with human bacteria degrades bile 
pigments, gives characteristic faecal odour, supply vitamin K to the host. 
Indicated in pathogenesis of carcinoma of large bowel.99% of bacterial flora is 
anaerobic. Bacterioides fragilis is most prevalent anaerobic bacteria. Aerobic 
bacteria are mainly Escheichia coli and streptococcus fecalis. Bacteria flora is 
readily altered by administration of oral neomycin. 
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LARGE INTESTINAL POLYPS AND TUMOURS 
            Large bowel is the most common site for a variety of benign and 
malignant tumours, majority of which are of epithelial origin. Most of the 
benign tumours present clinically as polyps. 
COLORECTAL POLYPS 
A polyp is defined as any growth or mass protruding from the mucous 
membrane into the lumen. Polyps are much more common in the large intestine 
than in the small intestine and are more common in the rectosigmoid colon than 
the proximal colon. Polyps are broadly classified into 2 groups— non-
neoplastic and neoplastic. Non-neoplastic polyps have further subtypes 
indicating their mode of origin. Neoplastic polyps, on the other hand, include 
epithelial tumours, both benign and malignant. 
I. COLORECTAL POLYPS 
A. Non-neoplastic polyps 
1. Hyperplastic (metaplastic) polyps 
2. Hamartomatous polyps 
(i) Peutz-Jeghers polyps and polyposis 
(ii) Juvenile (Retention) polyps and polyposis 
3. Inflammatory polyps (Pseudopolyps) 
4. Lymphoid polyps 
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B. Neoplastic polyps (Adenomas) 
1. Tubular adenoma (Adenomatous polyp) 
2. Villous adenoma (Villous papilloma) 
3. Tubulovillous adenoma (Papillary adenoma, villoglandular 
adenoma) 
C. Familial polyposis syndromes 
1. Familial polyposis coli (Adenomatosis) 
2. Gardner‘s syndrome 
3. Turcot‘s syndrome 
4. Juvenile polyposis syndrome 
II. OTHER BENIGN COLORECTAL TUMOURS 
(Leiomyomas, leiomyoblastoma, neurilemmoma, lipoma and  
Vascular tumours) 
III. MALIGNANT COLORECTAL TUMOURS 
A. Carcinoma 
1. Adenocarcinoma 
2. Other carcinomas 
(Mucinous  adenocarcinoma, signet-ring cell carcinoma, 
adenosquamous carcinoma, undifferentiated carcinoma) 
B. Other malignant tumours 
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(Leiomyosarcoma, malignant lymphoma, carcinoid tumours) 
 
A. NON-NEOPLASTIC POLYPS 
Non-neoplastic polyps are more common and include the following 4 subtypes: 
Hyperplastic (Metaplastic) Polyps : 
The hyperplastic or metaplastic polyps are the most common amongst all 
epithelial polyps, particularly in the rectosigmoid. They are called 
‗hyperplastic‘ because there is epithelial hyperplasia at the base of the crypts, 
and ‗metaplastic‘ as there are areas of cystic metaplasia. They may be seen at 
any age but are more common in the elderly (6th-7th decades). 
 
Grossly 
  Hyperplastic polyps are generally multiple, sessile, smooth-surfaced and 
small (less than 0.5 cm).  
 
Microscopically 
 They are composed of long and cystically dilated glands and crypts lined 
by normal epithelial cells. Their lining is partly flat and partly papillary. The 
luminal border of the lining epithelium is often serrated or saw toothed. 
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Hyperplastic polyps are usually symptomless and have no malignant potential 
unless there is a coexistent adenoma.  
 
Hamartomatous Polyps 
These are tumour-like lesions composed of abnormal mixture of tissues 
indigenous to the part.  
They are further of 2 types: 
 
PEUTZ-JEGHERS POLYPS AND POLYPOSIS: 
               Peutz- Jeghers syndrome is autosomal dominant defect, characterized 
by hamartomatous intestinal polyposis and melanotic pigmentation of lips, 
mouth and genitalia. The polyps may be located in the stomach, small intestine 
or colon but are most common in the jejunum and ileum. The most common age 
is adolescence and early childhood. 
Grossly 
             These polyps are of variable size but are often large, multiple and 
pedunculated and more commonly situated in the small intestine.  
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Microscopically: 
           The most characteristic feature is the treelike branching of muscularis 
mucosae. The lining epithelium is by normal-appearing epithelial cells. The 
glands may show hyperplasia and cystic change. Peutz-Jeghers polyps do not 
undergo malignant transformation unless a coexistent adenoma is present. 
However, patients with Peutz-Jeghers syndrome are more prone to certain other 
cancers such as of pancreas, lung, breast, ovary and uterus. 
 
JUVENILE (RETENTION) POLYPS. 
           Juvenile or retention polyps, another form of  hamartomatous polyps, 
occur more commonly in children below 5 years of age. Solitary juvenile 
polyps occur more often in the rectum, while juvenile polyposis may be present 
anywhere in the large bowel.  
Grossly 
Juvenile polyps are spherical, smooth-surfaced, about 2 cm in diameter 
and are often pedunculated. 
Microscopically 
             The classical appearance is of cystically dilated glands containing 
mucus and lined by normal mucus-secreting epithelium. The stroma may show 
inflammatory cell infiltrate if there is chronic ulceration of the surface. Most 
27 
 
cases, on becoming symptomatic in the form of rectal bleeding, are removed. In 
common with other non neoplastic polyps, they are also not precancerous. 
 
Inflammatory Polyps (Pseudopolyps)  
              Inflammatory polyps or pseudopolyps appear due to reepithelialisation 
of the undermined ulcers and overhanging margins in inflammatory bowel 
disease, most frequently in ulcerative colitis (colitis polyposa) and sometimes in 
Crohn‘s disease. 
Grossly 
             They are usually multiple, cylindrical to rounded overgrowths of 
mucosa and may vary from minute nodules to several centimeters in size.  
 
Microscopically 
The centre of inflammatory polyp consists of connective tissue core that 
shows some inflammatory cell infiltrate and is covered superficially by 
regenerating epithelial cells and some cystically-dilated glands. These lesions 
have no malignant potential; carcinomas seen in long-standing cases of 
ulcerative colitis arise in the region of epithelial dysplasia and not from the 
polyps. 
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Lymphoid Polyps 
Reactive hyperplasia of lymphoid tissue that is normally also more 
prominent in the rectum and terminal ileum, gives riseto  localised or diffuse 
lymphoid polyps, also called rectal tonsils. Localised form occurs more often in 
the rectum in elderly, while diffuse form is seen at younger age and in children. 
Grossly 
          They are solitary or multiple, tiny elevated lesions.  
Microscopically 
They are composed of prominent lymphoid follicles with germinal 
centres located in the submucosa and mucosa, and are covered by epithelium 
that may be inflamed. They are benign lesions and have to be distinguished 
from malignant lymphoma. 
 
B. NEOPLASTIC POLYPS (ADENOMAS) 
Neoplastic polyps are colorectal adenomas which have potential for 
malignant change while polypoid carcinoma is the term used for invasive 
epithelial tumours. Adenomas have 3 main varieties (tubular, villous and 
tubulovillous), each of which represents a difference in the growth pattern of 
the same neoplastic process and variable biological behaviour. 
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Tubular Adenoma (Adenomatous Polyp) 
Tubular adenomas or adenomatous polyps are the most common 
neoplastic polyps (75%). They are common beyond 3rd decade of life and have 
slight male preponderance. They occur most often in the distal colon and 
rectum. They may be found singly as sporadic cases, or multiple tubular 
adenomas as part of familial polyposis syndrome with autosomal dominant 
inheritance pattern. Tubular adenomas may remain asymptomatic or may 
manifest by rectal bleeding. 
 
Grossly 
Adenomatous polyps may be single or multiple, sessile or pedunculated, 
vary in size from less than 1 cm to large, spherical masses with an irregular 
surface. Usually, the larger lesions have recognisable stalks.  
Microscopically 
The usual appearance is of benign tumour overlying muscularis mucosa 
and is composed of branching tubules which are embedded in the lamina 
propria. The lining epithelial cells are of large intestinal type with diminished 
mucus secreting capacity, large nuclei and increased mitotic activity. However, 
tubular adenomas may show variable degree of cytological atypia ranging from 
atypical epithelium restricted within the glandular basement membrane called 
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as ‗carcinoma in situ‘ to invasion into the fibrovascular stromal core termed as 
frank adenocarcinoma. Malignant transformation is present in about 5% of 
tubular adenomas; the incidence being higher in larger adenomas. 
 
Villous Adenoma (Villous Papilloma) 
Villous adenomas or villous papillomas of the colon are much less 
common than tubular adenomas. The mean age at which they appear is 6th 
decade of life with approximatey equal sex incidence. They are seen most often 
in the distal colon and rectum, followed in decreasing frequency, by rest of the 
colon.  
Grossly 
Villous adenomas are round to oval exophytic masses, usually sessile, 
varying in size from 1 to 10 cm or more in diameter. Their surface may be 
haemorrhagic or ulcerated. 
Microscopically 
The characteristic histologic feature is the presence of many slender, 
finger-like villi, which appear to arise directly from the area of muscularis 
mucosae. Each of the papillae has fibrovascular stromal core that is covered by 
epithelial cells varying from apparently benign to anaplastic cells. Excess 
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mucus secretion is sometimes seen. Villous adenomas are invariably 
symptomatic; rectal bleeding, diarrhoea and mucus being the common features. 
The presence of severe atypia, carcinoma  in situ and invasive carcinoma are 
seen more frequently. Invasive carcinoma has been reported in 30% of villous 
adenomas. 
 
Tubulovillous Adenoma 
(Papillary Adenoma, Villoglandular Adenoma) 
Tubulovillous adenoma is an intermediate form of pattern between tubular 
adenoma and villous adenoma. It is also known by other names like papillary 
adenoma and villoglandular adenoma. The distribution of these adenomas is 
the same as for tubular adenomas. 
Grossly, 
Tubulovillous adenomas may be sessile or pedunculated and range in size from 
0.5-5 cm.  
Microscopically   
They show intermediate or mixed pattern, characteristic vertical villi and deeper 
part showing tubular pattern. The behaviour of tubulovillous adenoma is 
intermediate between tubular and villous adenomas. The contrasting features of 
non-neoplastic and neoplastic colorectal polyps are given in . 
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C. FAMILIAL POLYPOSIS SYNDROMES 
Familial polyposis syndromes are a group of disorders with multiple polyposis 
of the colon with autosomal dominant inheritance pattern. Important conditions 
included in familial polyposis are: 
1. Familial polyposis coli (adenomatosis) 
2. Gardner‘s syndrome 
3. Turcot‘s syndrome 
4. Juvenile polyposis syndrome 
Some other conditions in which multiple polyposis of colon occur but do not 
have familial basis are Peutz-Jeghers syndrome (hamartomatous), Cronkhite-
Canada syndrome (inflammatory), and nodular lymphoid hyperplasia. The 
familial polyposis syndromes are as follows. 
Familial Polyposis Coli (Adenomatosis) 
This hereditary disease is defined as the presence of more than 100 neoplastic 
polyps (adenomas) on the mucosal surface of the colon; the average number is 
about 1000. Adenomatosis can be distinguished from multiple adenomas in 
which the number of adenomas is fewer, not exceeding 100. The condition has 
autosomal dominant transmission and is due to germline mutations in APC gene 
which results in occurrence of hundreds of adenomas which progress to 
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invasive cancer. The average age at diagnosis is 2nd and 3rd decades of life 
with equal  incidence in both the sexes. 
Grossly and microscopically 
The commonest pattern is that of adenomatous polyps (tubular 
adenomas) discussed above. The malignant potential of familial polyposis coli 
is very high. Colorectal cancer develops virtually in 100% of cases by age of 50 
years if not treated with colectomy.  
Gardner’s Syndrome 
Gardner‘s syndrome is combination of familial polyposis coli and certain 
extra-colonic lesions such as multiple osteomas (particularly of the mandible 
and maxilla), sebaceous cysts and connective tissue tumours. The number of 
polyps in Gardner‘s syndrome is generally fewer than in the familial polyposis 
coli but their clinical behaviour is identical. 
 
Turcot’s Syndrome 
Turcot‘s syndrome is combination of familial polyposis coli and 
malignant neoplasms of the central nervous system. 
Juvenile Polyposis Syndrome 
           Juvenile polyposis is appearance of multiple juvenile polyps in the colon, 
stomach and small intestine but their number is not as high as in familial 
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polyposis coli. Family history in some cases may show autosomal dominant 
inheritance  pattern, while it may be negative in others. They resemble the 
typical juvenile polyps as regards their age (under 5 years), sex distribution and 
morphology. They lack the malignant potential. 
OTHER BENIGN TUMOURS 
Some non-epithelial benign tumours that may rarely occur in large 
intestine are leiomyomas, leiomyoblastoma, neurilemmoma, lipoma and 
vascular tumours (haemangioma, lymphangioma). 
MALIGNANT COLORECTAL TUMOURS 
A. Colorectal Carcinoma 
         Colorectal cancer comprises 98% of all malignant tumours of the large 
intestine. It is the commonest form of visceral cancer accounting for deaths 
from cancer in the United States, next only to lung cancer. The incidence of 
carcinoma of the large intestine rises with age; average age of patients is about 
60 years. Cancer in the rectum is more common in males than females in the 
ratio of 2:1, while at other locations in the large bowel the overall incidence is 
equal for both sexes. 
ETIOLOGY. 
         As with most other cancers, etiology of colorectal carcinoma is not clear 
but a few etiological factors have been implicated: 
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1. Geographic variations.  
2. The incidence of large bowel carcinoma shows wide variation throughout 
the world. It is much more common in North America, Northern Europe 
than in South America, Africa and Asia. Colorectal cancer is generally thought 
to be a disease of affluent societies because its incidence is directly correlated 
with the socioeconomic status of the countries. In Japan, however, colon cancer 
is much less common than in the US but the incidence of rectal cancer is 
similar. 
 
2. Dietary factors.  
        Diet plays a significant part in the causation of colorectal cancer:   
i) A low intake of vegetable fibre-diet leading to low stool bulk is associated 
with higher risk of colorectal cancer. 
ii) Consumption of large amounts of fatty foods by populations results in 
excessive cholesterol and their metabolites which may be carcinogenic. 
iii) Excessive consumption of refined carbohydrates that remain in contact with 
the colonic mucosa for prolonged duration changes the bacterial flora of the 
bowel, thus resulting in production of carcinogenic substances. 
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3. Adenoma-carcinoma sequence.  
      There is strong evidence to suggest that colonic adenocarcinoma evolves 
from preexisting adenomas, referred to as adenoma-carcinoma sequence . The 
following evidences are cited to support this hypothesis:  
i) In a case with early invasive cancer, the surrounding tissue often shows 
preceding changes of evolution from adenoma → hyperplasia → dysplasia → 
carcinoma in situ → invasive carcinoma. 
ii) Incidence of adenomas in a population is directly proportionate to the 
prevalence of colorectal cancer. 
iii) The risk of adenocarcinoma colon declines with endoscopic removal of all 
identified adenomas. 
iv) Peak incidence of adenomas generally preceded by some years to a few 
decades the peak incidence for colorectal cancer. 
v) The risk of malignancy increases with the following 
adenoma-related factors: 
a) Number of adenomas: familial polyposis coli syndrome 
almost certainly evolves into malignancy. 
b) Size of adenomas: large size increases the risk. 
c) Type of adenomas: greater villous component associated 
with higher prevalence. 
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4. Hereditary non-polyposis colonic cancer (HNPCC or 
Lynch syndrome). 
• No polyps. Autosomal dominant 
• Three members of the family have colonic cancers 
• Two first degree relatives will have same cancer 
• Two consecutive generations observed 
• One relative with less than 50 years age will have 
colonic cancer 
• Lynch syndrome I is site specific - commonly right 
sided, occurs in early age group, 40% are metachronous 
• Lynch syndrome II has other malignancy in, stomach,  
breast, ovary, endometrium and urinary bladder. 
• Accounts for 3-5% of colonic cancers 
• Amsterdam criteria I (1990); Amsterdam criteria II 
(1999) and revised Bethesda guidelines (2002) are 
used to diagnose HNCC 
       There are germline mutations in mismatch repair genes, human mutL 
homolog abbreviated as hMLH2 located on chromosome 2 and hMLH1 on 
chromosome 3 resulting in DNA instability( Microsatellite instability (MSI) at 
DNA level occurs)in HNCC. 
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     colon cancer appears at a relatively younger age (<50 years), association 
with multiple primary cancers at different sites (e.g. endometrium, ovary), 
preferred location in proximal colon and better prognosis than other sporadic 
colon cancer cases. 
5. Other factors. 
 Presence of certain pre-existing diseases such as inflammatory bowel 
disease (especially ulcerative colitis) and diverticular disease for long duration 
increase the risk of developing colorectal cancer subsequently. It may be 
recalled here that low fibre diet is implicated in the pathogenesis of diverticular 
disease as well. Besides, there is an etiologic role of tobacco smoking in 
development of colorectal cancer in younger patients. 
 
GENETIC BASIS OF COLORECTAL CARCINOGENESIS. 
Studies by molecular genetics have revealed that there are sequential 
multistep mutations in evolution of colorectal cancer from adenomas by one of 
the following two mechanisms: 
1. APC mutation/ β-catenin mechanism.  
This pathway of multiple mutations is generally associated with 
morphologically identifiable changes as described above in adenoma-carcinoma 
sequence. These changes are as under: 
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i) Loss of tumour suppressor APC (adenomatous  polyposis coli) gene located 
on the long arm of chromosome 5 (5q) is present in 80% cases of sporadic 
colon cancer. Since the function ofAPC gene is linked to β-catenin, loss of APC 
gene results in translocation of β-catenin to the nucleus where it activates 
transcription of other genes, mainly MYC and cyclin D1, both of which 
stimulate cell proliferation.  
ii) Point mutation in K-RAS gene follows loss of APC gene and is seen in 10 to 
50% cases of adenoma-carcinoma. 
 
iii) Deletion of DCC gene located on long arm of chromosome 18 i.e. 18q 
(DCC for deleted in colorectal cancer) in 60-70% cases of colon cancer.  
iv) Loss of p53 tumour suppressor gene seen in 70-80% cases of colon cancer. 
 
2. Microsatellite instability mechanism.  
In this pathway also, there are multiple mutations but of different genes, and 
unlike APC mutation/β-catenin mechanism there are no morphologically 
identifiable changes. This pathway accounts for 10-15% cases of colon cancer. 
Basic mutation is loss of DNA repair gene. This results in a situation in which 
repetitive DNA sequences (i.e. microsatellites) become unstable during 
replication cycle, termed Microsatellite instability,  which is the hallmark of this 
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pathway. The significant DNA repair genes which are mutated in colon cancer 
are as under:  
i) TGF-β receptor gene which normally inhibits cell proliferation but in mutated 
form allows the uncontrolled proliferation of colonic epithelium in adenoma. 
ii) BAX gene which normally causes apoptosis but a defect in 
it results in loss of apoptosis and dysregulated growth. 
     MORPHOLOGIC FEATURES. 
          Distribution of the primary colorectal cancer reveals that about 60% of 
the cases occur in the rectum, followed in descending order, by sigmoid and 
descending colon (25%), caecum and ileocaecal valve (10%); ascending colon, 
hepatic and splenic flexures (5%); and quite uncommonly in the transverse 
colon . 
Grossly 
There are distinct differences between the growth on the right and left half of 
the colon 
Right-sided colonic growths  
           Tend to be large, cauliflower- like, soft and friable masses projecting 
into the lumen(fungating polypoid carcinoma). 
 
 
41 
 
Left-sided colonic growths 
           On the other hand, have napkin-ring configuration i.e. they encircle the 
bowel wall circumferentially with increased fibrous tissue forming annular ring, 
and have central ulceration on the surface with slightly elevated margins 
(carcinomatous ulcers). 
These differences in right and left colonic growths are probably due to 
the liquid nature of the contents in the ascending colon leaving space for 
luminal growth on right side, while the contents in left colon are more solid 
permitting the spread of growth into the bowel wall. However, early lesion in 
left as well  as right colon are small, button-like areas of elevation. 
Microscopically 
The appearance of right and left-sided growths is similar. About 95% of 
colorectal carcinomas are adenocarcinomas of varying grades of differentiation, 
out of which approximately 10% are mucin-secreting colloid carcinomas. The 
remaining 5% tumours include uncommon microscopic patterns like 
undifferentiated carcinoma, signet-ring cell carcinoma, and adenosquamous 
carcinomas seen in more distal colon near the anus. The histologic grades 
indicating the degree of differentiation are: well-differentiated, moderately 
differentiated and poorly-differentiated. 
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SPREAD. 
Carcinoma of the large intestine may spread by the following routes: 
1. Direct spread.  
The tumour spreads most commonly by direct extension in both ways— 
circumferentially into the bowel wall as well as directly into the depth of the 
bowel wall to the serosa, pericolic fat, and sometimes into peritoneal cavity.   
Locally, 
 it can invade the bladder, obstruct ureter and  so cause hydronephrosis.  
 • Can perforate and cause peritonitis/pericolic abscess/faecal fistula. 
 • Growth may get adherent to psoas muscle posteriorly. 
 • Carcinoma sigmoid colon can infiltrate and cause colovesical or colovaginal       
   fistula. It can infiltrate ureter, ovary, uterus etc. It can cause pericolic abscess 
or abscess in lateral abdominal wall. 
 
2. Lymphatic spread 
Spread via lymphatics occurs rather commonly and involves, firstly the 
regional lymph nodes in the vicinity of the tumour, and then into other groups 
of lymph nodes like preaortic, internal iliac and the sacral lymph nodes.  
• Growth through lymphatics spreads to pericolic, epicolic, intermediate and 
principal group of lymph nodes. 
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3. Haematogenous spread. 
 Blood spread of large bowel cancer occurs relatively late and involves the 
liver, lungs, brain, bones and ovary. 
     CLINICAL FEATURES 
Clinical symptoms in colorectal cancer appear after considerable time. These 
are as follows: 
i) Occult bleeding (melaena) 
ii) Change in bowel habits, more often in left-sided growth 
iii) Loss of weight (cachexia) 
iv) Loss of appetite (anorexia) 
v) Anaemia, weakness, malaise. 
The most common complications are obstruction and haemorrhage; less often 
perforation and secondary infection may occur. Aside from the diagnostic 
methods like stool test for occult blood, PR examination, proctoscopy, 
radiographic contrast studies and CT scan, recently the role of tumour markers 
has been emphasized. Of particular importance is the estimation of carcino 
embryonic antigen (CEA) level which is elevated in 100% cases of metastatic 
colorectal cancers, while it is positive in 20-40% of early lesions, and 60-70% 
of advanced primary lesions. However, the test may have prognostic 
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significance only and is not diagnostic of colorectal cancer because it is positive 
in other cancers too. Such as of the lungs, breast, ovary, urinary bladder  and 
prostate. CEA levels are elevated in some non-neoplastic conditions also like in 
ulcerative colitis, pancreatitis and alcoholic cirrhosis. 
 
STAGING AND PROGNOSIS  
The prognosis of colorectal cancer depends upon a few variables: 
i) Extent of the bowel involvement 
ii) Presence or absence of metastases 
iii) Histologic grade of the tumour 
iv) Location of the tumour 
Three staging systems are in use: 
1. Dukes‘ ABC staging (modified Duke‘s includes stage D as well). 
2. Astler-Coller staging which is a further modification of Duke‘s staging and is 
most widely used. 
3. TNM staging described by American Joint Committee is also used. 
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     Histology (WHO) 
• Adenocarcinoma – 90%. 
• Mucinous adenocarcinoma – 5-10%. 
• Signet ring cell carcinoma. 
• Small cell/oat cell carcinoma – rare – extremely poorprognosis. 
• Squamous cell carcinoma. 
• Undifferentiated carcinoma. 
Duke‘s histological grading of carcinoma colon (Nowmodified Morson-
Dawson) 
• Grade I- low grade. 
• Grade II- average grade. 
• Grade III- high grade. 
• Grade IV- anaplastic. 
Haggitt’s Invasion of Malignant Polyp 
In pedunculated polyp 
Level 0 – non invasive carcinoma over the summit. 
Level 1 – invasion to head  
Level 2 – invasion to neck. 
Level 3 – invasion to stalk. 
Level 4 – invasion to base. 
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In sessile polyp – all lesions are level 4. 
Sessile Malignant Polyp Invasion 
Sm 1 – Submucosal invasion into upper 1/3 (superficial/inner). 
Sm 2 – Submucosal invasion into middle 1/3 (inner 2/3). 
Sm 3 – Submucosal invasion lower 1/3 (deep). 
STAGING OF CARCINOMA COLON 
DUKE’S 
A. Confined to bowel wall, mucosa and submucosa 
B. Extends across the bowel wall to the muscularis propria with no lymph 
nodes involved 
C. Lymph nodes are involved 
D. wide spread metastasis 
MODIFIED DUKE’S 
A -  Tumour confined to bowel mucosa 
B1 -Tumour involves the muscle wall but not completely 
B2 -Involves the serosa  
C1 -Tumour involves the muscle wall but not completely 
       Local lymph nodes involved 
C2 - Involves the serosa 
      Local lymph nodes involved 
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ASTLER-COLLER’S 
A: Limited to mucosa 
B1: Extending into muscularis propria but not penetrating through it; nodes not 
involved 
B2: Penetrating through muscularis propria; nodes not involved 
C1: Extending into muscularis propria but not penetrating through it. Nodes 
involved 
C2: Penetrating through muscularis propria. Nodes involved 
D: Distant metastatic spread 
 
Groups of Lymph Nodes Draining Colon 
• N1: Nodes immediately adjacent to bowel wall. 
• N2: Nodes along ileo colic/right colic/middle colic/ 
         left colic/sigmoid arteries. 
• N3: Nodes near the origin of SMA and IMA. 
• Nodal spread in carcinoma colon is sequential from 
  N1 → N2 → N3. 
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Blood spread: 
• 40% of carcinoma colon spreads to liver via portal veins. 
• Secondaries may be either solitary or multiple, present as liver with hard,     
   umbilicated nodules– Rarely it spreads to bone, lung, skin. 
. 
TNM Staging 
T0-primary could not be assessed 
Tis—Carcinoma in situ. 
T1—Invasion into submucosa. 
T2—Into muscularis propria 
T3—Tumor invades through the muscularis propria into the subserosa, or into       
        nonperitonealized  pericolic or perirectal tissues 
T4—Tumor directly invades other organs or structures and/or perforates  
        visceral peritoneum 
     NX-Regional lymph nodes cannot be assessed 
N0—No nodes. 
N1—Up to 3 nodes. 
N2—4 or more nodes. 
M0—No metastasis. 
M1—Metastasis present. 
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R0 – No residual tumour after resection; 
R1 – Microscopic residual tumour after resection; 
R2 – Macroscopic residual tumour. 
 
     B. Other Colorectal Malignant Tumours 
Aside from colorectal carcinoma, other malignant tumours 
which are encountered sometimes in the large bowel are 
leiomyosarcoma  and malignant lymphoma . Hindgut carcinoids may occur in 
the rectum and colon. 
    SCREENING  
Screening Guidelines for Colorectal Cancer 
 
 
Population Initial Age Recommended Screening Test 
Average risk 50 y Annual FOBT or 
    Flexible sigmoidoscopy every 5 
y or 
    Annual FOBT and flexible 
sigmoidoscopy every 5 y or 
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    Air-contrast barium enema every 
5 y or 
    Colonoscopy every 10 y 
Adenomatous 
polyps 
50 y Colonoscopy at first detection; 
then colonoscopy in 3 y 
    If no further polyps, colonoscopy 
every 5 y 
    If polyps, colonoscopy every 3 y 
    Annual colonoscopy for >5 
adenomas 
Colorectal cancer At diagnosis Pretreatment colonoscopy; then 
at 12 mo after curative resection; 
then colonoscopy after 3 y; then 
colonoscopy every 5 y, if no new 
lesions 
Ulcerative colitis, 
Crohn's colitis 
At diagnosis; then 
after 8 y for 
pancolitis, after 15 
Colonoscopy with multiple 
biopsies every 1–2 y 
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y for left-sided 
colitis 
FAP 10–12 y Annual flexible sigmoidoscopy 
    Upper endoscopy every 1–3 y 
after polyps appear 
Attenuated FAP 20 y Annual flexible sigmoidoscopy 
    Upper endoscopy every 1–3 y 
after polyps appear 
HNPCC 20–25 y Colonoscopy every 1–2 y 
    Endometrial aspiration biopsy 
every 1–2 y 
Familial 
colorectal cancer 
first-degree 
relative 
40 y or 10 y before 
the age of the 
youngest affected 
relative 
Colonoscopy every 5 y 
Increase frequency if multiple 
family members are affected, 
especially before 50 y 
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FAECAL OCCULT BLOOD TESTING: (FOBT ) 
FOBT analysis is found to be one of the cost effective methods in finding out 
the patients in need of colonoscopy and so it forms an important part of the 
screening methods for colorectal carcinoma. 
 
 RATIONALE OF FOBT 
            Faecal occult  blood  test  is  based  on  the  tendency  of  colorectal  
tumour  and  large  polyps  to  bleed. 
            Single  faecal  occult  blood  test  was  not  sufficient  and  has  no  
clinical  significance  in  screening. By  one  spot  FOBT  screening  the  
detection  rate  of  adenoma  and  carcinomas  was  2/1000  and  0.6/1000  
respectively. 
          FOBT screening has no benefit without appropriate followup and 
treatment. This  is a  screening  test  that  shows  a  subgroup  of  average  risk  
asymptomatic  people  likely  to  have  serious  colorectal carcinoma  to  justify  
more  costly  and  invasive  diagnostic  tests. The FOBT itself  neither  rules out  
nor  rules  in  colonic  cancer. 
        Few  drops  of  water  before  adding  hydrogen  peroxide  gives  more  
positive  results  thereby  increasing  sensitivity  and  decreasing  specificity. 
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           Some  tests  are  unaffected  by  dietary  peroxidases  (ex) hemoquant  
test  based  on  conversion  of  heme  to  porphyrin . it  also  has the  advantage  
of estimating  the amount  of  blood  lost  in  stool, but  this  test  was the   most  
expensive  than  the  conventional  FOBT  and  therefore this  test  is  unsuitable  
for  screening  programmes. 
 
            One  of  the  major  disadvantage  of  all  faecal  blood  tests  is  that  
colorectal  tumours  and  polyps  bleed  intermittently  and  distribution   of  
blood  is  uneven  in  stools. Faecal  occult  blood  test  signifies  the  presence  
of  possible  cancers  and  polyps. 
COMPLIANCE : 
              Stool  collection  for  FOBT  screening   is  an  unpleasant  work , this  
explains why  even  in  RCT  settings  not  more  than  2/3  of  people  are  
compliant .outside  the  randomized  control  trials  compliance  is  much  
lower. 
 
ANNUAL FOBT vs BIENNIAL FOBT : 
                  One  of  the  largest  randomized trial  which  last  for  13 year  
follow  up(Minnesota  trial) clearly  shows  there  is  definitive  33%  reduction  
of  mortality by  annual  faecal  occult  blood  test. 
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            Testing  every  2 years (biennial  screening) resulted  only  6%  
reduction  of  mortality. Thus annual FOBT  is  much  more  effective  than  
biennial  FOBT. 
 
FAECAL MICRO RNA vs FOBT : 
              Cancer society  of  America  guidelines  includes  faecal  DNA  test  as  
recommended  screening  test  for  colorectal  tumours. Upto this date  faecal  
DNA  test  was  the  only  test  based  on  molecular  biology  techniques  which  
is  commercially  available. 
             Faecal  DNA  test  and  cox 2  test  for  colorectal  cancer  screening  
was  reported  first  in  2004. 
                  Recently faecal miRNA  (micro RNA) in  faeces  was  used  in  
CRC  screening .  microRNA  was  extracted   from FOBT  residuum.  This is  
stable  at  4 degree C  than  at  room  temperature.  Faecal miRNA  degraded  at  
37 degree C  but  PCR  amplification is  used  under  these  situations.   
 
DNA  STOOL  EXAMINATION : 
              Colorectal  tumour  can  be  diagnosed  by  extraction  of altered DNA  
from  stool. In  one  study  it  has  a  sensitivity  of  90%  and  specificity  of  
80%  for  polyps  with  size  1cm  or  larger. 
55 
 
But  these  tests  are  highly  expensive .Hopefully  these expenses can be  
reduced  in   large  scale  screening  tests. The   reported  sensitivity  and  
sensitivity  of  stool  DNA  examination should be confirmed  by  large  scale  
studies. 
       In  future ,it would be  ideal  if  DNA  testing  may  be  incorporated  into  
the  so  called ― SMART  TOILET‖(an  intelligence  toilet  system  designed  
by  japan  ) – which  can  measure  sugar  levels  in  urine. 
   
NEWER  FOBTS – IMMUNOCHEMICAL  FOBT: 
            These  test  detects  intact  human  haemoglobin.   Other  advantages  of  
immunochemical  FOBT  over   guaiac  based  FOBT  is  that ,  iFOBT  does  
not  detect  partly  digested  haemoglobin  that  comes  from  upper  
gastrointestinal  tract  and  respiratory  tract. 
          The  initial  study  shows  iFOBT  have  sensitivity  and  specificity  
compared  with  colonoscopy. 
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PRETREATMENT EVALUATION:  
 Demographic data(age, sex, race,etc) 
 Complete medical history 
 Genetic assessment for those with family or personal history of colorectal ca 
 General and systemic examination(DRE,PV, PROCTOSCOPY) 
 Haemogram, biochemistry, etc 
 Serum CEA 
 Pretreatment imaging(DCBE, CT, EUS, MRI, PET) 
 Colonoscopy,virtual colonoscopy(MR or CT) 
• CEA (Carcinoembryonic antigen): 
– It is a cell surface glycoprotein discovered by Gold and Freedman. 
– It is normally produced by colonic epithelium. 
– Its serum ½ life is up to 10 days and is cleared by liver through Kupffer cells. 
So its ½ life prolongs in cholestasis and hepatocellular dysfunction. 
– Normal level is < 2.5 ng/ml. Level > 5 ng/ml is 
significant. 
– Even though it is a widely used tumour marker, 
it has got low sensitivity. 
conditions like pancreatitis, hepatitis, obstructive jaundice, BPH. 
– Uses in colorectal cancers are: 
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a. Preoperative levels >7.5 ng/ml signifies poor 
prognosis. 
b. If postoperative level does not fall, it indicates either incomplete resection, or 
occult metastasis elsewhere. 
c. Increase CEA during follow-up indicates recurrence 
orsecondaries. 
– A slow rise indicates loco regional disease. 
– A rapid rise signifies metastasis. 
– It is not useful in assessing follow-up in poorly 
differentiated adenocarcinoma as such tumour 
will not produce CEA. 
BARIUM ENEMA 
              The barium enema gives good anatomic and topographic information 
that not only may be sufficient to diagnose a polyp or carcinoma but also 
demonstrates the site and configuration of the lesion, and the presence or 
absence of diverticulosis. The anatomic position of a cancer is clearly of great 
importance to a surgeon planning an operation. Discrimination for small lesions 
and mucosal abnormalities is considerably enhanced by the double-contrast 
technique rather than the single-contrast enema. The air insufflated after the 
barium shows clearly the mucosal destruction from an ulcerated carcinoma or 
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the mucosal coating of both adenomatous polyps and polypoid carcinomas. 
Only double-contrast assessments are appropriate in the assessment of the 
cancer patient. In the presence of partial obstruction, a soluble-contrast 
evaluation with gastrografin may be more suitable 
CT 
            CT scans of the chest, abdomen, and pelvis with oral, intravenous, 
rectum contrast are essential in patients with cancer of the colon. They are 
informative for identifying the primary tumor location, assessing extramural 
extension in patients with colon or rectal cancer and for detecting metastatic 
disease in distant organs or regional lymph node basin 
ERUS (Endorectal Ultrasound) AND MRI 
        High resolution contrast MRI and EUS should be considered as the initial 
modalities to assess T stage.EUS is better in differentiating T1-T2 lesions while 
MRI is more appropriate for large T3-T4 lesions. However, both modalities 
have  difficulty in determining the borderline T2,T3 due to presence of 
desmoplastic reation around tumour 
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T stage Ultrasound Findings 
uT1 Confined to the mucosa and submucosa 
uT2 Invading into but not through the muscularis propria 
uT3 Invading into the perirectal fat 
uT4 Invading into an adjacent organ 
 
COLONOSCOPY 
           Colonoscopy has now become the optimal diagnostic tool for most 
diseases of the large bowel and a major therapeutic modality as well. Certainly, 
small lesions (less than 1 cm), and mucosal as well as some submucosal 
conditions (colitis, angiodysplasia), are better demonstrated by colonoscopy. . 
While barium enema is only a diagnostic tool, with the colonoscope one can 
biopsy, remove, ablate, dilate, and even at times achieve hemostasis. Since in 
all colonoscopies there are potential blind spots (at flexures, for example) and 
occasionally the cecum cannot be intubated, there is still occasional need to 
complement colonoscopy with contrast radiography. 
Contraindications: 
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Absolute contraindications: inadequate preparation, fulminant colitis, when 
perforation is suspected or peritonitis established, and in the presence of a 
recently created intestinal anastomosis. 
Relative contraindications:  acute inflammation (a limited, careful examination 
by an experience endoscopist may be vital to the diagnosis of ischemia or acute 
colitis 
Indications: 
For diagnostic colonoscopy, 
       the evaluation of signs, symptoms or history of colitis, resolution of 
abnormal findings from barium enema, evaluation of all categories of bleeding 
,surveillance of high-risk patients for adenomas and cancer and intraoperative 
localization of non-palpable lesions (in open or laparoscopic procedures). 
For therapeutic colonoscopy  
1. hemostasis (vascular malformations, polypectomy site, malignant lesions); 
2. resection and ablation (polyps, malignancy); 
3. decompression and  recanalization  (volvulus, pseudo-obstruction, stricture 
malignancy, foreign body). 
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Equipment: 
        Colonoscopes are now available as fiberoptic or video instruments. . At 
least 160 cm of working length is desirable and an instrument channel of at 
least 3.7 mm in diameter. One needs an assortment of biopsy forceps, grasping 
forceps, cytology brushes, polypectomy snares, retrieval devices ( baskets or 
graspers), injection needles, possibly laser fibers, and at least a monopolar 
cautery device. 
Preparation and procedure: 
       Thorough mechanical bowel preparation is required before colonoscopy 
and is currently most efficiently obtained with rapid gut lavage by ingestion of a 
polyethylene glycol electrolyte lavage solution. Intravenous narcotics and 
sedatives are commonly administered, but many patients undergo the procedure 
without any medication. It is customary to monitor the patient during the 
procedure with pulse oximetry and  sphygmomanometry. The endoscopist, be 
they gastroenterologist, surgeon or radiologist, should be qualified to perform 
the procedure and should have received training in the use of electrocautery as 
well as fluoroscopic equipment. Modern colonoscopes are constructed so that 
the instrument controls can be manipulated with the left hand; the right hand is 
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available for insertion of the instrument as well as twisting to the left or right 
(torquing). 
The patient is customarily placed in the left lateral recumbent position to begin 
the procedure, unless a stoma is being intubated. The perianal area is examined, 
rectal examination performed, and the instrument is inserted. Once the rectum 
has been intubated, a small amount of air is inflated to visualize the lumen and 
the instrument is progressively advanced with the right hand, the tip being 
deflected with the controls of the left hand. The landmarks on reaching the 
cecum include visualization of the ileocecal valve and the appendiceal orifice. 
Precise localization may not be as necessary for a lesion seen anywhere in the 
right colon, since the surgical procedure will be usually the same. However, it is 
important to determine where a lesion is in the transverse or sigmoid colon, 
since different decisions may be made based on such localization. Obstacles to 
reaching the cecum include poor preparation, strictures, large tumors, and 
inability to straighten the sigmoid as from previous pelvic operations, radiation 
or sometimes from extensive diverticular disease. 
Complications: 
       The most serious complications of colonoscopy are perforation and 
bleeding. Perforation occurs during diagnostic procedures in some 0.1 to 0.5 per 
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cent of examinations. Causes of perforation include longitudinal tears of the 
mesentery from excessive looping, especially in the sigmoid, distraction of the 
bowel wall from a similar maneuver, or impaction of the tip of the endoscope in 
a diverticulum. Manipulation of irradiated or inflamed bowel, of course, poses a 
greater risk.  
       This type of perforation at colonoscopy usually requires prompt surgical 
intervention and repair, often without the need for colostomy as the bowel will 
have been well prepared mechanically. Perforation following polypectomy, on 
the other hand, is usually from transmural thermal injury and may be delayed. 
Management will depend on the patient's status at the time perforation is 
recognized. Certainly the presence of signs of peritoneal irritation mandate 
intervention. 
VIRTUAL COLONOSCOPY 
Virtual colonoscopy is a relatively new and novel way to screen for colon        
 polyps and cancers. new scanners, in combination with sophisticated three- 
 dimensional (3D) software packages, now make virtual colonoscopy more  
 accurate, affordable, and user friendly. 
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     Magnesium citrate, phosphor soda, and polyethylene glycol solutions used in 
colon preparation, , elderly patients or patients with renal or cardiac issues 
cannot take phosphor soda, and therefore we use polyethylene glycol for these 
patients. Stool tagging is a method by which residual stool in the colon is 
―tagged‖ with a high-density contrast agent so that it can be easily identified on 
CT . If stool tagging is not used, it is often difficult or impossible to distinguish 
small stool particles from polyps. Stool tagging consists of both solid and liquid 
stool tagging. Solid stool tagging is accomplished with diluted barium agents. 
,Iodinated oral contrast is  administrated the day before the CT colonoscopy in 
liquid tagging.This is a liquid water-soluble iodine-based contrast agent that 
increases the density of any residual fluid. , it is essential that polyps greater 
than 5 mm (especially those ≥1 cm) be detected with high sensitivity and 
specificity. Virtual colonoscopy has limited sensitivity and specificity for 
lesions smaller than 5 mm. However, because polyps of less than 5 mm are 
almost never malignant, the detection of these small lesions is not crucial, 
especially if the patient will be screened at regular 5- to 10-year intervals 
Limitations  
1, radiation issue 
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2, Residual stool( can mask or simulate polyps. However, as described earlier, 
the use of the fecal solid and liquid tagging agents greatly reduces this 
difficulty.) 
3, cost. 
4, current lack of sufficient radiologist training. 
      FDG-PET 
            18
F-Fluorodeoxyglucose positron emission tomography  imaging has been 
successfully used in the diagnosis, staging, and treatment monitoring for a 
number f cancers, including ovarian, breast, lung, and colorectal.  
Basic Theory : 
18
F-FDG is preferentially taken up by metabolically active cells with up 
regulated cell surface glucose transporters and increased rate of glycolysis. 
Images can be displayed in a coronal, sagittal, and transverse manner. Normal 
PET scans demonstrate physiologic 
18
F-FDG uptake in the brain, heart, colon, 
bladder, stomach, kidney, spleen, liver, and bone marrow. the resolution of PET 
images is currently limited in lesions below 1 cm 
Screening and Staging of Colorectal Cancer :  
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detect both malignant and premalignant colorectal lesions. However, the 
sensitivity is dependent on the size and the grade of dysplasia. For example, it 
has been reported that 
18
F-FDG-PET detects 100% of colorectal cancers 2 cm or 
larger but only 17% of cancers smaller than 2 cm, including premalignant 
adenomas 
In terms of staging, limitation is due to resolution of PET scanners and signal 
overlap with the primary tumor. Given the higher sensitivity of magnetic 
resonance imaging (MRI) and endorectal ultrasound (EUS), 
18
F-FDG-PET in its 
present form does not appear to provide any further reliable information on 
regional lymph node staging in patients with rectal cancer. Therefore the 
potential role of 
18
F-FDG-PET in the initial staging of colorectal cancer is the 
detection of distant disease.  
Assessment of Response to Neoadjuvant Therapy in Rectal Cancer : 
CT, MRI, and EUS appear unable to assess response because they cannot 
accurately differentiate scar, fibrosis, and viable tumor. Although the sensitivity 
of 
18
F-FDG-PET may be reduced after recent chemotherapy, because it has 
been suggested that in patients with a great response to neoadjuvant therapy 
local surgical approaches could be an alternative to radical surgery, assessment 
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of response by 
18
F-FDG-PET may have the potential to identify these patients 
preoperatively 
Follow-up and Management of Recurrent Colorectal Cancer : 
First, if used routinely, 
18
F-FDG-PET may detect and localize unsuspected 
locally recurrent and distant metastatic colorectal lesions. Second, 
18
F-FDG-
PET may help differentiate among scar, fibrosis, and viable tumor in cases in 
which recurrent colorectal cancer is suspected or other imaging modalities show 
no evidence of disease despite an elevated carcinoembryonic antigen (CEA). 
Third, 
18
F-FDG-PET may help to determine resectability in patients with 
diagnosed recurrent colorectal cancer at high risk for unresectable disease. 
18
F-FDG-PET is a valuable tool in patients with a rising CEA and can detect 
recurrent disease with a positive predictive value of 89% and a negative 
predictive value of 100% in patients in whom conventional imaging techniques 
show no evidence for recurrent local or distant disease. 
For recurrent colorectal cancer, 
18
F-FDG-PET shows promise and may 
currently be used to (1) verify nonspecific findings detected on conventional 
imaging modalities, (2) evaluate an unexplained CEA elevation, and (3) 
identify occult unresectable disease preoperatively. 
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Predicting Resectability: 
    18
F-FDG-PET as a whole-body imaging technique is the most accurate 
imaging modality for detecting extrahepatic disease and that it can predict the 
patients who are most likely to benefit from a second surgical procedure. 
    PET-CT: 
PET/CT is significantly more accurate than PET or CT alone for staging and 
restaging colorectal cancer 
Summary   
          Its role in the screening for and the initial local staging of colorectal 
cancer may be limited, in patients with suspected distant disease 
18
F-FDG-PET 
can help to determine operability. In terms of rectal cancer response to 
neoadjuvant therapy, 
18
F-FDG-PET has clear advantages compared with other 
imaging modalities and may be able to predict response early during the course 
of treatment. The use of 
18
F-FDG-PET during follow-up of colorectal cancer 
patients has yet to be defined. However, for patients with suspected recurrent 
disease, 
18
F-FDG-PET can be used to determine unresectable disease and 
therefore identify patients unlikely to benefit from an exploratory laparotomy 
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Imaging techniques and their specific role in staging 
 primary tumour: MRI&EUS 
 CRM assessment: MRI 
 Nodal staging: MRI&EUS 
 Metastatic work up: CECT  abdomen and chest 
 Post neoadjuvant therapy: MRI, PET-CT 
TREATMENT: 
Aims of treatment: 
Relieve symptoms and prolong survival 
Prevent or minimize the locoregional recurrence and distant metastasis 
Preserve urinary and sexual function 
Preserve sphincter function whenever possible 
Surgical treatment of colon cancer 
Right colon cancers 
        Right hemicolectomy is the standard operation for cancers of the cecum 
and ascending colon, removing as little of the terminal ileum The 'space of 
Treves' is medial to the ileocolic artery, with an absence of lymphatics. Hence, 
taking more than 10 to 15 cm of ileum will not add to the nodal clearance. The 
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right colic artery is also ligated at its origin. It is a variable vessel, branching 
from the ileocolic, superior mesenteric artery directly, or from the right branch 
of the middle colic. Some patients do not have any definable 'right colic' artery. 
The distal extent of colon removed depends upon the site of the tumor. The 
resection may need to extend to the mid-transverse colon for cancers near the 
hepatic flexure, which always requires entering the lesser sac with clearance 
along the right gastroepiploic vessels and head of the pancreas. The terminal 
ileum is then anastomosed to the transverse colon in one or two layers with 
sutures or staples. The anastomosis may be end to end, end-to-side, or side-to 
side.  
In younger and slender patients, lymphadenectomy may be carried out along the 
superior mesenteric vein to the uncinate process of the pancreas. It is important 
to remember that the superior mesenteric vein is to the right of the superior 
mesenteric artery, and may be damaged during aggressive mobilization and 
dissection. It is a thin-walled structure, not easily repaired. Bleeding at the root 
of the mesentery should not be dealt with by deep sutures placed 'blindly'. If 
bleeding occurs, the vessels should be dissected and repaired under direct 
vision. A thrombosed or occluded superior mesenteric vein at this location will 
lead to infarction of the entire small bowel. The duodenum and pancreas are 
also at risk during mobilization of the hepatic flexure.  
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Transverse colectomy 
       The lymphatic drainage for cancers of the transverse colon is along the 
middle colic vessels to the root of the superior mesenteric artery. Resection 
therefore removes most of the colon supplied by the middle colic artery and in 
particular the splenic flexure, where thepericolic vascular arcade may be 
incomplete (The ascending colon is often resected to facilitate reconstruction 
and avoid a mesenteric 'trap'. The omentum is removed en bloc with the tumor, 
leaving the gastroepiploic vessels. The most common procedure involves a right 
and transverse colectomy, with ileal reconstruction to the descending colon.  
Left hemicolectomy 
      For cancers at the splenic flexure, descending colon, or proximal sigmoid 
colon, a left hemicolectomy is performed .Nodal drainage from the splenic 
flexure is more common toward the left colic than the middle colic. Generous 
exposure is necessary to provide good access to the splenic flexure, which is 
often high and contiguous with the spleen. The lesser sac must be opened The 
proximal resection should include the splenic flexure because the ascending left 
colic artery is ligated at its origin and the pericolic anastomosis is often 
insufficient to ensure a good blood supply to the anastomosis. The transverse 
colon is mobilized sufficiently to perform a tension-free anastomosis. The 
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inferior mesenteric artery is seldom ligated at its origin, but should it be 
necessary to take this vessel because of nodal metastases, the distal resection 
should be extended to the proximal rectum, which is adequately supplied from 
the middle rectal artery. 
 
Sigmoid and rectosigmoid colectomy 
     Cancers of the mid or low sigmoid colon are resected with either a sigmoid 
or full left hemicolectomy. In either case, resection of the superior hemorrhoidal 
(rectal) artery is essential. Resection of the inferior mesenteric artery with full 
mobilization of the splenic flexure and left colectomy is based on the size and 
exact location of the patient's tumor, the redundancy of the sigmoid, nodal 
findings, age, general medical condition, and body habitus. 
Management of rectal cancer 
Combined modality treatment: 
     All locally advanced rectal cancer require multimodality treatment which 
includes surgery,radiotherapy and chemotherapy.Correct sequencing of these 
has been evaluated and debated for last several decades. 
PREOPERATIVE THERAPY; 
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     The era of preoperative therapy started as short course radiotherapy[without 
concurrent chemotherapy]in 1970‘s.In the 1980‘s,postoperative chemotherapy 
showed survival benefit in carcinoma colon .Preoperative chemoradiation thus 
become the standard of care for patients with cT3 and /or node positive tumors. 
        
     PREOPERATIVE CHEMORADIATION: 
ADVANTAGES: 
1. Biologic: Decreased tumor seeding at the time of surgery and increased 
responsiveness to radiotherapy as tumor cells are better oxygenated. 
2. Physical: No post surgical bowel fixation in pelvis and hence reduced dose to 
bowel. 
3.Functional:Increased resectability in previously unresectable locally advanced 
disease and better chances of sphincter preservation even in low lying tumors. 
DISADVANTAGES: 
1. over treatment of patients due to overstaging of T1-2N0 tumors 
2. Delay in surgical treatment 
3. Uncertainity in deciding post-operative adjuvant treatment in absence of 
initial pathological staging 
POSTOPERATIVE CHEMORADIATION 
ADVANTAGES: 
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1. Precise knowledge of tumor stage available. 
2. Accurate definition of tumor bed available by surgical clips 
3. avoidance of over treatment 
DISADVANTAGES: 
1. Small bowel in radiation fields leading to higher rate of complications 
2. Potentially hypoxic tumor bed 
3. potentially compromised margins for bulky tumors fixed to surrounding 
structures or pelvic side wall 
4.If APR is done radiation fields have to be extended to cover scar 
Approaches in preoperative treatment: 
There are two main approaches of preoperative therapy for resectable rectal 
cancer 
1.Short course preoperative radiotherapy(SCRT) 
2.Long course preoperative radiotherapy with concurrent chemotherapy 
The incidence of positive CRM was lower following CTRT compared with 
SCRT. 
Time interval between completion of CTRTand surgery: 
Traditionally, radical surgery is recommended 6 weeks after completion of 
CTRT but retrospective data indicate  that surgery performed more than 7 to 8 
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weeks after completion of CTRT results in higher rates of  ypCR and improved 
outcome. 
 
 
 
 
 
 
 
 
Short course(SCRT) Long course(CTRT) 
Eligible clinical stage cT1-3/n0 cT3-4 and / or N+ 
Treatment schedule only RT 5Gy/fraction 
x 5 days[25 Gy] 
RT 1.8 Gy/fraction 
over 5-6 weeks[45-
50.4GY]with 
concurrent 5-FU based 
chemo 
Interval between RT 
and surgery 
5 days 4-8 weeks 
Concurrent 
chemotherapy 
No yes 
Sphincter preservation No  yes 
Improved local control yes yes 
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     SURGERY: 
Surgery remains the only curative modality of treatment for rectal cancer 
and the most important determinant of long-term oncologic results 
SURGICAL PROCEDURES: 
A. Sphincter saving  procedure 
-Anterior resection 
-Low anterior resection 
-Intersphincteric resection 
-Local excision 
-Transanal excision [transanal] 
-TEM [Transanal endoscopic microsurgery] 
B. Abdominoperineal resection [APR] 
- When the sphincter is involved by disease 
-Negative margins cannot be achieved by sphincter saving  procedures. 
-elderly and frail patients where sphincter is already compromised [incontinent 
patient] 
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FACTORS DECIDING THE CHOICE OF PROCEDURES: 
-Patient factors-age, comorbidities ,status of anal sphincter and pelvic floor ,and 
patient‘s wish. 
-Tumor location-extraperitoneally located  tumors are more suited for local 
excision[i.e.below the middle rectal valve].Similarly, distance from anal verge 
is an important criteria in addition to sphincter involvement to decide between 
anterior dissection[AR] and abdominoperineal resection[APR] 
-Tumor stage-depth of invasion of rectal wall, lymph node involvement, size of 
tumor and rectal circumference involved ,histological features[grade ,mucinous  
or non mucinous, depth of penetration, lymphovascular and perineural 
invasion]. 
PREOPERATIVE COUNSELLING: 
     A detailed discussion about the disease status and treatment option with their 
merits and demerits with the patient and family helps in informed decision 
making ultimately culminating into a properly taken informed consent . 
A trained person should counsel all those likely to have temporary or permanent 
stoma care ,preferably several days before the surgery.  stoma marking is done 
after inspecting the contours of abdominal wall in lying down, sitting and 
standing position. 
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TECHNIQUE OF TOTAL MESORECTAL EXCISION: 
BASIC PRINCIPLE OF TOTAL MESORECTAL EXCISION: 
I. Sharp dissection either with electrocautery or scissors under good 
lighting and direct vision. 
II. The plane should be opened gently by continuous traction and 
counter traction avoiding tearing or riping apart of tissues. 
III. Posteriorly,the avascular plane [holy plane]lies in the loose areolar 
tissue which lies between the visceral and parietal layers of 
endopelvic fascia. 
IV. Circumferential excision of mesorectum. 
V. Laterally inside the plane of pelvic plexus. 
EXTENT OF MESORECTAL EXCISION: 
       The tumor usually spreads into the lymphatics of mesorectum 
approximately 2 to 5cm distal to the rectal lesion, hence following is the 
recommendation for the mesorectal excision. 
Upper rectal growth-5cm of mesorectal excision distal to the tumor 
Mid and lower rectum-total mesorectal excision 
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DISTAL RESECTION MARGIN: 
           Intramural microscopic tumor extension is usually restricted to within 
2cm from grossly visible distal margin of the tumor with more than 2cm distal 
spread found only in approximately in 2.5% of patients. 
-1 to 2cm distal mural margin is adequate for majority 
-8 to 10mm margin is adequate in patients who have had excellent response to 
chemoradiation 
-2cm distal margin is suggested for poorly differentiated carcinoma 
An intraoperative frozen section control may further help in confirming 
negative distal margin. 
TECHNIQUE OF TOTAL MESORECTAL EXCISION: 
Position: Lithotomy, trendelenburg  or Lloyd-davies position. 
Anaesthesia: Generalanaesthesia  with endotracheal intubation and Foleys 
catheter. 
Incision: Long midline incision[or laproscopic ports for lap TME] 
Dissection is divided into six zones 
 Above the pelvic brim: 
-Divide the peritoneum to sigmoid colon near it base after it pulling the sigmoid  
anteromedially 
-Identify the loose areolar tissue at the back of mesosigmoid. 
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-Plane between the back of mesosigmoid and parietal fascia is entered ,ureter 
and superior hypogastric nerves are identified. 
-Divide inferior mesenteric artery distal to left colic artery or at the site of 
division of sigmoid colon. However, lymph nodes from the root of inferior 
mesenteric artery should be included in the specimen. 
 At sacral promontory and posterior dissection: 
-make a plane between superior rectal artery and superior hypogastric plexus. 
-enter the retrorctal space between the mesorectum and the parietal layer of the 
endopelvic fascia [loose shiny areolar tissue] 
-continue dissection up to the sacrorectal ligament [S4 level],a dense connective 
tissue layer. 
-divide the ligament sharply to reach the pelvic floor. 
Along the pelvic side wall [lateral dissection] 
-Identify the presacral superior hypogastric plexus [sympathetic nerves]and 
dissect the left hypogastric nerves away from the visceral fascia. 
-Similar plane is entered on the right side 
The lateral ligament containing the nerves of the rectum from the pelvic plexus 
are situated 2 to 3 cm below the peritoneum, lateral to rectum. This hardly 
contains any significant vessels and can be easily divided with cautery/scissor. 
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No clamping should be done to avoid nerve injury. The precise dissection plane 
here is most difficult to identify. 
 Anterior dissection: 
-Division of peritoneum 1cm above the rectovesicle reflection behind the 
seminal vesicles and posterior border of prostate. 
-plane lies anterior to denonvilliers  fascia, which is divided transversely at the 
base of the prostate [or vaginal vault].Further dissection is continued distally 
upto pelvic floor posterior to the fascia except in anterior transmural tumors 
when this fascia included in this level also.In females the vaginal wall and 
rectum should be dissected carefully an sufficiently to avoid vaginal injury 
during anastomosis which could result in recto vaginal fistula. 
 Extreme distal dissection: 
After the mesorectum has been dissected down to the pelvic floor ,3 to 4 cm of 
rectum is cleared of mesorectal fat for anastomosis. 
RECONSTRUCTION AFTER SPHINCTER SAVING RESECTION: 
        Several techniques of reconstruction have been described with studies 
reporting superiority of one over the other in terms of functional outcome. 
However long-term does not indicate better quality of life with anyone 
technique over the other.  
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-Straight colorectal/coloanal anastomosis 
-Side to end colorectal/coloanal anastomosis 
-Colonic pouch anal anastomosis 
-Coloplasty 
PROXIMAL DIVERSION [EITHER ILEOSTOMY OR TRANSVERSE 
COLOSTOMY] 
           Diversion is not required routinely,but it is should be judiciously used in 
select group of patients,some of which are as follows. 
-Anastomosis <7cm from anal verge 
-TME 
-Male gender 
-obese patient 
-Straight coloanal anastomosis 
-Technical mishap during surgery 
-Preoperative CTRT 
-Significant intraoperative bleeding and hypotension. 
Local excision: 
         Local excision [LE] is an acceptable alternative to radical surgery in 
patients unfit for major surgery although at a cost of poorer oncologic outcome. 
LE has been assessed as an alternative to TME in  selected only stage rectal 
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cancer s because it is less invasive,avoids colostomy and is associated with 
lesser morbidity and mortality. 
Criteria: 
1. T1, well to moderately differentiated lesion 
2. sizeupto 3cm involving less than a third of rectal circumference 
3. No lymphovascular [LVI] or perineural[PNI] invasion or mucinous feature 
on histopathology. 
4. T1N0 tumors on EUS and MRI 
5. Clear margins of resection 
Even in T1 tumors with no adverse features [as mentioned above],there is a 10 
to 15% incidence of lymph node metastasis which cannot be addressed  by LE. 
All T2 tumors and T1 tumors with high –risk features on histology [poor 
differentiation ,presence of LVI or PNI ,lymph node positivity]must be 
subjected to radical resection unless contraindicated in which as adjuvant CTRT 
is adviced to improved local recurrence and survival. 
There may also be a role of LE in selected patients with T2 and T3 tumours 
having excellent response to CTRT and who are unfit for or refuse more radical 
surgery. The available data suggests local recurrence and survival data 
comparable to TME but requires further validation. 
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Transanal excision and Transanal endoscopic microsurgery: 
        The conventional transanal excision[TAE] is appropriate for lower lesions 
while Transanal endoscopic microsurgery[TEM] offers better visualization and 
access for mid and upper rectal lesion.TEM also follows dissection to be  more 
precise, makes resection of large tumor easier and improves lymph node harvest 
.Although TEM is superior to TAE in terms of achieving negative margins and 
lower local recurrence ,it does not translate into significant survival 
advantage.TEM also requires expensive equipment and has a steep learning 
curve 
      ABDOMINOPERINEAL RESECTION: 
The preoperative preparation and the abdominal portion of the procedure are 
similar to the anterior resection of the rectum; therefore, the perineal resection 
is described here. 
Perineal resection 
the key anatomic landmarks: the perineal body, right and left ischialtuberosities, 
and coccyx. An elliptic incision extending from the perineal body to the coccyx 
is drawn with an indelible pen . The skin is incised with  scalpel deepened down 
through the subcutaneous tissue. The perianal skin ellipse is grasped with three 
Allis clamps, and the subcutaneous tissue is further divided with electrocautery. 
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Dissection proceeds directly down toward the coccyx. A moon-shaped incision 
is made at the tip of the coccyx, and the anococcygeal raphe is identified. The 
anococcygeal raphe is sharply divided with electrocautery. The Waldeyer fascia 
is encountered next and sharply divided to enter the presacral space. Laterally, 
the superficial fascia is divided to enter the ischiorectal fossa on both sides. The 
fat within the ischiorectal fascia is divided along the same furrow created on the 
lateral aspect. It is prudent to conceptualize the boundaries of the ischiorectal 
fossa: 
 
• Laterally, the ischial tuberosity and the obturator fascia overlying the 
extrapelvic portion of the obturatorinternus 
 
• Medially, the infra-anal fascia covering the levatorani and the sphincter 
ani muscles 
 
• Ventrally, the transverse perineal superficialis and profundus muscles 
 
• Dorsally, the fascia of the gluteus maximus muscle 
In the upper part of the ischiorectal fossa, the inferior hemorrhoidal vessels are 
clamped, divided, and ligated with 2-0 absorbable sutures. Electrocoagulating 
these vessels must be avoided because they tend to retract, causing bleeding at a 
later point postoperatively. Once the ischiorectal fossa has been opened 
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bilaterally, a self-retaining St. Mark‘s retractor is placed to facilitate further 
exposure. Posterior dissection is continued by elevating the anal canal with a 
malleable retractor and dividing the areolar tissue between the presacral fascia 
and the rectal fascia with electrocautery. The anal canal and then the rectum are 
progressively elevated from the presacral fascia, avoiding dissection too close 
to the sacrum because this can lead to troublesome bleeding from the presacral 
veins. Conversely, dissection too far anteriorly should be avoided to prevent 
risk of entering the rectum. If necessary, the abdominal operator should be 
allowed to direct the perineal dissector into the proper plane. In addition, it is 
important to keep a mental note of the curves of the rectum as the posterior 
dissection proceeds. 
The index and middle fingers are passed beneath the iliococcygeus muscle on 
the right and then the left side, and the iliococcygeus muscles are divided 
sequentially with electrocautery or Metzenbaum scissors .The lateral dissection 
is continued ventrally by dividing the pubococcygeal muscle. The rectum still 
remains suspended by the puborectalis sling muscle. This muscle is placed 
under tension with the use of two malleable retractors in the lateral space, one 
laterally to retract the ischiorectal fat and the other medially over the rectum. 
The puborectalis muscles are divided in a longitudinal fashion on each side, 
thus allowing the rectum to fall dorsally. It is important to avoid drifting too far 
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ventrally, because this may result in injury to the urethra. It is prudent to feel for 
the catheter within the urethra intermittently during this dissection. After the 
posterior dissection has been completed, the clamped sigmoid end of the 
operative specimen is drawn out through the posterior end of the perineal 
wound until the sigmoid and the upper two thirds of the rectum have been 
delivered out of the pelvic cavity. 
The anterior dissection is now started. It is the most difficult portion of the 
perineal dissection because the rectum/anal sphincters are closely attached to 
membranous urethra, prostate, and seminal vesicles. The anterior skin is 
retracted while downward traction on the anal skin ellipse is applied to reveal 
the plane of dissection. The posterior border of the transverse perineal muscle is 
exposed. The rectourethralis is divided in the midline, and the plane between 
the rectum and the prostate is entered. The remaining anterior attachments are 
thinned by progressively dividing tissues on the sides. Again, it is important to 
palpate the Foley catheter and the prostate intermittently to avoid injury to these 
structures. Near the final stages of the dissection, it is important to support the 
rectum because it can be easily avulsed off the prostate or the urethra, which 
can result in inadvertent injury and troublesome bleeding. 
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The empty pelvic cavity is irrigated, and bleeding points are secured with a 
combination of electrocautery and suture ligatures using 2-0 absorbable sutures. 
If there is concern regarding hemostasis within the pelvis, it should be packed. 
Otherwise, two closed suction drains are placed in the pelvis and secured with 
3-0 nonabsorbable sutures. 
Closure: 
The skin is approximated with interrupted mattress sutures using 3-0 
monofilament nonabsorbable sutures 
 
ADJUVANT THERAPY: 
Role of postoperative adjuvant chemotherapy: 
Indications for chemotherapy 
• Positive nodes. 
• T4 lesions. 
• Venous (microscopic) spread. 
• Signet cell type. 
• Poorly differentiated tumour/aneuploidy. 
• Changes in CEA level. 
Postoperative chemotherapy is used commonly. 
89 
 
Occasionally also given preoperatively. 
Regimes are - 
• 5 Fluorouracil (5 FU) with folinic acid (leucoverin/ LV) is the most 
commonly used regime for 6 months as monthly cycles. Folinic acid potentiates 
the action of 5 FU. 
• Levamisole 150 mg/day for 3 days given once in 15 days for one year with 
intravenous 5 FU monthly for one year. 
• Irinotecan/5 FU/LV – IFL regime is also used. 
• Folinic acid (LV)/5 FU/oxaliplatin – FOLFOX regime is also used. It is 
becoming treatment of choice. 
• Irinotecan/oxaliplatin – IROX regime is used in previously untreated 
metastatic colonic cancer. 
• Capecitabine (xeloda) an oral drug which generates 5 FU at tumour tissue, 
shows significantly greater response than 5 FU/LV regime. 
• Phase II trials are going on for capecitabine/oxaliplatin and 
capecitabine/irinotecan combination regimes. 
• 5 FU infusions into the portal vein during and immediately after surgery have 
shown benefits in terms of outcome and recurrence. 
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EGFR and VEGF blockers (EGFR is epithelial growth factor receptor; VEGF 
is vascular endothelial growth factor)— 
• They are used as single agent and also in combination with chemotherapy 
drugs in phase II and III trial. 
• Drugs are monoclonal antibody, cetuximab which blocks EGFR, bevacizumab 
which binds VEGF. 
 
The routine practice is to add four to six months of postoperative adjuvant 
chemotherapy using 5FU,leuocovorin and oxaliplatin [folfox] in patients who 
have received preoperative radiation or chemoradiation. 
 
 Post operative radiotheraphy 
            Patients with pT3N0 tumours with either adverse pathological    
     features,resected without TME or in whom less than 12 nodes are examined 
     should receive post operative CTRT. 
RECENT ADVANCES 
1.induction chemotheraphy and use of additional chemotheraphy  cycles during 
the resting period after completion of radiotheraphy 
2.capicitabine   oral prodrug of  5-fluoro uracil, widely used due to ease of 
administration and decreased adverse effects 
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3.Complete clinical  response of pre operative CTRT: 
A significant proportion of cases with complete clinical response who undergo 
radical surgery have residual tumour of histopathology which has led to the use 
of radical surgery in all patients. Local recurrence was higher in the group 
managed  non operatively. However this approach needs very close surveillance 
to detect and treat recurrence early. 
4. Response to CTRT-The biomarkers 
Molecular biology information to identify patients who are likely to have 
greater or complete response to non operative therapy. DNA microarray other 
biomarkers are also being evaluated to predict response to therapy like 
epidermal growth factor receptor (EGFR),P53,Ki-67,P21,Bcl2/Bax,etc.. 
5. Enhanced recovery after surgery protocol 
ERAS pathway is to attenuate stress response to surgery and facilitate rapid 
recovery, reduce the length of hospital stay and post-opertaive complication. 
ERAS pathway includes avoidance of preoperative polyetheleneglycol  bowel 
preparation, consuming  of carbohydrate  rich solution 3 hours before to 
surgery. Use of total intravenous anesthesia, early  mobilization in post 
operative field, avoidance of  NG tube and abdominal drains,  intake of liquids 
and solid foods in early post operative field, minimising opiates for pain control 
and use of bowel stimulating drugs . 
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6.Extralevator technique in abdomino-perinealReseach 
The traditional APR involves taking a cuff of levator muscle around the rectum, 
increases CRM positivity is likely to be due to tapering and ultimately absent, 
mesorectum at the level of levatorani that result in coning in towards rectum at 
this level, while following the plane of TME from abdominal side. In addition, 
access and vision often poor at the level of pelvic floor leading to higher 
specimen perforation and CRM involvement 
To circumvent this problem, more radical cylindrical – type APR 
(ExtralevatorAPR ). The abdominal dissection stops at the level levators, 
abdominal is closed. And patient turned to prone jack knife position perineal 
dissection takes place in extralevator plane cutting the levator at their 
attachment to pelvic side wall providing a very wide cuff of levator around the 
rectum. In anteriorly located tumor apart of prostate or vaginal wall will be 
resected EN-BLOC. Perineal defect may require with Mesh and / flap to avoid 
wound related morbidity. 
 
7. Recent advances in in RT 
Précise  localisation of target and delivery of treatment by 3D conformal 
therapy (SDCRT) and IMRT (Intensity Modulated Radio Therapy) and IGRT 
(Image Guided Radio Therapy). 
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Guidelines for Surveillance after Surgery and Adjuvant Therapy for 
Colorectal Cancer 
History and 
Physical 
Examination 
Every 3 Months for 2 Years and Then Every 6 Months for 
a Total of 5 Years 
CEA 
Every 3 months for 2 years and then every 6 months for 5 
years for lesions ≥T2 
Colonoscopy 
Perform in 1 year. If abnormal, repeat in 1 year. If no 
polyps found, repeat every 2–3 years. If a preoperative 
colonoscopy could not be performed  because of 
obstruction, must be done in 3–6 months. For patients with 
rectal cancer who did not receive pelvic radiation, 
alternatives may include a flexible sigmoidoscopy every 6 
months for 5 years. 
CT scans 
May be considered  annually for people at high risk of 
recurrence as defined by poorly differentiated histologic 
grade and tumors with perineural or venous invasion. If the 
patient is postmetastectomy for synchronous liver disease, 
the recommendation for CT scans may be increased to 
every 3–6 months. 
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MATERIALS AND METHODS: 
 
Patients admitted in various surgical units in thanjavur medical college hospital 
between January 2013  to july 2014  constitute the materials of this study.  
Patients admitted with complaints of abdominal pain , dyspepsia and other non 
specific compliants not related to colorectal symptoms were included in this 
study.  
The exclusion criteria includes  patients with complaints of bleeding PR, altered 
bowel habits , tenesmus , mucus discharge from PR, spurious diarrhea ,mass 
desending PR ,FOBT within last one year, sigmoidoscopy within last 3 to 5 
years, colonoscopy within last 10 years. 
The inclusion criteria includes patients with age of 50 and above, patients 
willing for further followup ( invasive procedures like colonoscopy&UGI 
scopy) 
All patients subjected to basic blood,urine and biochemical evaluation including 
liver function tests ,USG abdomen ,UGI scopy and CT abdomen in selected 
cases. 
General condition of the patient is evaluated , presense of features like anaemia, 
lymphadenopathy, pallor, jaundice are noted. 
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Examination of cardiovascular, respiratory and skeletal system was done. 
Thorough examination of abdomen ( looking for abdominal pain, any mass per 
abdomen , distention , ascites ) was done. Per rectal examination was done in all 
cases. 
A total  of 200  patients were studied, patients with positive faecal occult blood 
test are included in this study, those who are negative for FOBT were  adviced  
for follow up, one year later for another FOBT test.  
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RESULTS     
 
1. FOBT  POSITIVITY 
 
NO. OF PATIENTS FOBT +VE FOBT –VE 
200 52 148 
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2. AGE DISTRIBUTION OF FOBT POSITIVITY 
AGE IN 
YEARS 
50-60 60-70 70-80 
NO OF 
PATIENTS 
42 7 3 
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3. SEX DISTRIBUTION OF FOBT POSITIVITY 
 
SEX MALE FEMALE 
NO OF PATIENTS 40 12 
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4. FOLLOW – UP STATUS 
 
 
 
 
 
 
  
FOLLOW - UP
REGULAR
IRREGULAR
FOLLOW – UP REGULAR IRREGULAR 
NO OF PATIENTS 40 12 
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4. NUMBER OF PATIENTS WITH POSITIVE COLONOSCOPY 
 
NO OF PATIENTS POSITIVE 
COLONOSCOPY 
NEGATIVE 
COLONOSCOPY 
40  9 31 
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6. CAUSES OF FOBT POSITIVITY 
CAUSE
S 
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C 
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PS 
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     DISCUSSION 
DEFINITION OF SCREENING 
          By examining  asymptomatic people in order to classify them as likely or 
unlikely to have the disease. 
          People who are positive in screening test are likely to go through further 
investigations to arrive at a final diagnosis. The motive of screening test is early 
detection of disease, so early treatment is much more easy and effective than 
later management. 
       The results of screening test designated either positive if patient is 
identified to have disease or negative if they are not.  Mostly all screening tests 
have their own negative points in the form of test itself or by its interpretation. 
These drawbacks are designated as false positive (in this the patient without 
disease will have positive screening result) and false negative (in this patient 
with disease will have negative screening result) results. 
          The sensitivity of the test is defined as ―the probability that a person with 
disease has a positive test result‖. 
         The specificity of test is test is defined as ―the probability that a person 
without disease has a negative test result‖. 
          Screening programmes are mainly assessed by comparing disease 
mortality in the presence or absence of screening. Evaluation of screening 
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programmes are done either by comparing screening groups control group as in 
randomized control trials (or) by comparing mortality before and after the 
introduction of screening test. 
  
     COLORECTAL CANCER SCREENING 
        All colorectal tumours pass through a long  detectable  precancerous  
phase  as a  polyp in bowel lumen . By  early  detection  and  removal  of  polyp  
these  type   of  cancers    are  easily  prevented.  Even though  carcinomas  are  
detected  in  established   early  stage  it   has  a  better  prognosis  than its  
detection  in  the  later  stage  of  tumour  progression.  These features make 
colorectal carcinoma as an   ideal  disease   for  screening. A lot  of  screening  
tests  are  available  for  colorectal  cancer  ranging   from   low  cost  and  
moderately  effective  occult blood  tests  to  highly  expensive  and  more 
effective  colonoscopy. 
   Four  major   randomized control  trials   clearly  shows  there  was  an   
overall  reduction  in  mortality( 26%) by  faecal  occult  blood  test  (mandel et 
al  ,hard castle et.al,  kewenter  et.al,  kronborg et al ). 
                Greegor (1961)   first  reported  the  effectiveness  of  faecal  occult     
      blood  test  by  detecting  asymptomatic  colorectal cancer  patients  by  using   
     guaiac  impregnated  test  cards. 
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               Though  many  different  chemicals  are   used  to  detect  faecal  
blood  the   guaiac   test,  haemoccult-ii    continue  to  be  one  of   the  most  
commonly  recommended  tests   because  of  high  specificity , low  cost  and  
simplicity. 
 
    This  test  is  done  for  three  consecutive  bowel  movements . this  test  is  
done  by  taking  stool  samples  from  different  sites  using  some  applicator  
stick  and  smeared  into  two  windows  in  one  slide. 
 
            FOBT  based  on  colour  change  is  mainly  due  to  pseudoperoxidase    
activity  of  haemoglobin.  positive  test  doesn‘t  tell  about  the  amount  of  
blood being  lost,  so  this  test  was  not  specific  for  tumours  because  non  
cancerous  lesions  such  as  gum  bleeding, gastric  ulcer, peptic  ulcer  disease  
and  haemorrhoids will  also  give  positive  result  because  bleeding  will  also  
be  present  in  these  conditions.                           
            The  test  is  not  specific  for  blood  itself  because  other substances 
with peroxidase  and  pseudoperoxidase  activity (meat , some fruits, vegetables 
bacteria) also  give  false  positive  result  ,if  these  substances  are  present  in  
stool  sample. because of these drawbacks  screening  subjects  are  adviced  to  
follow  diet  restriction  before  going  to  test. 
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                 Some  substances  block  pseudoperoxidase  activity  and  give  false  
positive  results (ascorbicacid) .Positive  test  may  revert  to  negative  if  the  
slides  are  stored  in  lab  for  more  than  few  days  prior  to  
screening.rehydration  of  test  slides  by  adding  patients  with  positive  
screening  results  must  undergo  definitive  diagnostic  evaluation  by  double  
contrast  barium  enema with  or  without  flexible  sigmoidoscope  and  
colonoscopy. 
FOBT in Thanjavur medical college: 
Benzidine hydrochloride , barium peroxide , 5 ml of glacial acetic acid all these 
mixed in test tube. a clean class stick dipped in faecal matter is smeared in 
white paper a little benzidine solution poured over that white paper. 
Deep blue colour within 15 sec indicates strong positive, Greenish blue within 
30 sec indicate weakly positive, No colour within 30 sec indicates negative test. 
     INFLUENCEOF  DIET  IN  FOBT 
Experiments   in  food  stuffs  indicates  uncooked  and  untreated  vegetable   
or  animal  tissue  gives  a  positive  result  which  was  reduced   or  nullified  
by   cooking. beef  and  mutton  are  exceptions .In  fish  kingdom  sardines  and  
salmon  retain  their  positivity  even  after  cooking. In our study, 20% of the 
study population was found to be vegetarians.  So, the dietary predisposition 
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toward non-vegetarian diet seems to be the contributory factor towards the 
incidence of colorectal carcinoma and thus subsequently FOBT positivity. 
INSTRUCTION  ON DIET  CONTROL  BEFORE  TEST: 
Foods that  must  be  avoided  are,  
1) Salmon and  sardines 
2) Mutton, beef  &  soup  and  sausage 
3) Rabbit, pigeon 
4) Turnip 
5) Unboiled vegetables . 
Collect   first   three motions   available from the third   
day onwards.  
     ADHERENCE  TO  SCREENING 
        The advantage of  screening  occurs  only  if  eligible  population    are  
accurately  screened .But  problems   with  screening  adherence  is  mainly  due  
to  low  income,   un education  and  unawareness  of  population . 
Recent  study  shows  people  may  adhere  more  with  faecal  test  than  
colonoscopy. 
         Is our study, only 77 percentages of people who were found to be having 
FOBT positivity attended futher colonoscopic evaluation. 
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SENSITIVITY : 
         Bleeding  from  CRC  will  not  be  present  in  all  cases  of  CRC ,  this  
explains  the  low  sensitivity  of  FOBT  in  CRC  screening. The  actual  
sensitivity  will  not  be  more  than  55%  , even though the  sensitivity  for  
polyp  is  much  Lower than  carcinoma   But  FOBT  undoubtedly  detects  
some  polyps, explaining  the  long  term  follow  up  period  and  annual  
testing   for  reduction  in  mortality  of  CRC. 
SPECIFICITY:  
               Specificity of  this  test  is  around  95% , but  FOBT  is  used  as  a 
screening  procedure  for the  general  population-say  persons  above  50 years-  
the   positive  predictive  value  of  less  than  6-10 %.  
        In our study, patients with negative FOBT not subjected to colonoscopy, 
so it was not possible to calculate sensitivity (false positive) and specificity 
(true negative) 
      COST :  
                Guaiac faecal occult blood test itself is very cheap but positive          
     screening  test requires additional expensive tests, which may be negative        
      at the end. In our study, this being a government instituition, the test was done  
     free of cost to all the patients. The government has to spend around thirty  
     rupees for each analysis. 
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CAUSES OF FOBT POSITIVITY: 
         In our study, only 9 patients had treatable diseases among those with 
FOBT positivity.  Of them, 6 had haemorrhoids, 1 had a polyp and a carcinoma 
each and one other patient had diverticulum.  Eventhough the numbers are 
statistically negligible, the interventions done in these patients in the form of 
polypectomy and haemorrhoidectomy  according to the associated pathologies 
helped in improving the quality of  the precious life of those patients.  
 
       A special mention has to be made about the patient who was identified 
to have the carcinoma.  The disease was diagnosed at an earlier stage in 
this patient and the patient subsequently underwent curative surgery.  
Thus even as the number is statistically insignificant,  our screening with 
FOBT has helped in saving the life of that patient.  
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CONCLUSION: 
 
 Faecal  occult blood test screening offers no benefit without appropriate 
follow up diagnostic tests and treatment. 
 Single occult blood test examination has no clinical significance in 
colorectal cancer screening. 
 Colonoscopy is more superior to all other screening tests in colorectal cancer 
screening. 
 Colonoscopy offers both diagnostic and therapeutic options. 
 It is simple, safe and cost effective but is limited by lack of acceptability, 
compliance and adherence as well as poor sensitivity and specificity. 
 In India, where there is scarcity of resources, in order to have population 
impact FOBT is the most affordable test. 
 In considering all the advantages and drawbacks of FOBT in colorectal 
cancer screening, we can conclude that this examination is certainly better 
than no testing at all. 
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PROFORMA 
 
NAME  :        
AGE/SEX : 
I.P. NO.  : 
UNIT  :        
OCCUPATION : 
ADDRESS :        
DATE OF ADMISSION : 
DATE OF DISCHARGE : 
PRESENTING COMPLAINTS : 
HISTORY OF PRESENTING ILLNESS  : 
            Abdominal pain 
            Dyspepsia 
            Constipation 
           vomiting      
           Bleeding per rectum    
           altered bowel habits              
           tenesmus                  
           haematemesis/malena    
           mucous discharge     
           Loss of wt/appetite     
PAST HISTORY : 
 h/o previous colonoscopy   
 h/o previous gi surgeries   
 h/o NSAID intake     
 h/o previous FOBT    
116 
 
 h/o DM/HT/BA/TB 
PERSONAL HISTORY : 
diet 
appetite 
smoking 
alcohol 
GENERAL EXAMINATION : 
Anaemia:   
 icterus: 
  BP :      
  pulse :  
SYSTEMIC EXAMINATION: 
CVS : 
RS : 
P/A : 
P/R      : 
FOBT   : 
COLONOSCOPY: 
HISTOPATHOLOGICAL REPORT OF BIOPSY : 
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 1  asokan           57 M   
47823     
+ _ _ + NV N N Renal 
calculi(b/l) 
N conservative 
2 Saroja 61 F 56023 + _ _ + NV N diverticulum N N conservative 
3 Charles 58 M 43461 + _ _ _ VEG N N N N conservative 
4 ravi 51 M 41209 _ _ _ + NV N haemorrhoids N N surgery 
5 Saraswathi 63 F 40127 + _ _ + NV N N N N  
conservative 
6 Manivel 50 M 57012 _ _ _ + NV N N N APD Anti ulcer 
drugs 
7 kamalraj 55 M 44301 + _ _ _ NV N N Simple 
liver cyst 
N conservative 
8 Umarani 52 F 45834 _ _ + _ NV N N N N conservative 
9 Balasundar 56 M 47812 _ + _ _ NV N Polyp N N Polypectomy 
10 Balraj 51 M 48126 + _ _ _ VEG N N Type 1 
RPD 
APD Anti ulcer 
drugs 
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1 1   natarajan         52 M 48201      + _ _ + NV N N N APD Anti ulcer 
drugs 
12 Selvaraj 54 M 55123 + _ _ _ NV N N Renal 
calculi(r) 
N conservative 
13 Ramani 62 F 48567 + _ _ _ NV N N N N conservative 
14 Ganapathy 56 M 48923 _ + + _ VEG N N N N conservative 
15 Veerammal 53 F 67690 _ _ _  
+ 
NV N haemorrhiods N N conservative 
16 Thasthageer 64 M 45670 + _ _ _ NV N N N N conservative 
17 Subramanian 55 M 48452 + _ _ + NV N carcinoma 
rectum 
N N Anterior 
resection 
18 Thiyagarajan 61 M 74623 _ _ _ + VEG N N N N conservative 
19 Karupaiya 51 M 51236 _ _ + _ NV N N N APD Anti ulcer 
drugs 
20 Muthulakshmi 57 F 44562 + _ _ + NV N N Renal 
cortical 
cyst(b/l) 
N conservative 
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 21 Srinivasan 53 M 43276       _ + _ _ VEG N haemorrhoids N N surgery 
22 magesh 52 M 58445 + _ + _ NV N N N N conservative 
23 Tamilarasi 54 F 49551 _ _ + _ NV N N N N conservative 
24 Arumugam 63 M 60112 + _ _ _ NV N N Ureteric 
calculi-L 
 
N Conservative 
25 Sankar 51 M 58342 _ _ _ + NV N N N N conservative 
26 vasanthi 54 F 47901 + + _ _ NV N N N N conservative 
27 Ganesan 52 M 38987 + _ _ _ VEG N haemorrhoids N N haemorrhoidectomy 
28 Mani 58 F 47564 _ _ + _ NV N N N N conservative 
29 Karikalan 54 M 39033 + _ _ _ NV N N N APD Anti ulcer drugs 
30 vijayan 55 M 58965 + _ _ _ NV N N RT-VUJ 
calculus 
N Ureteroscopy by 
urologist 
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DRE-digital rectal examination, APD-acid peptic disease, VUJ-vesicoureteral junction,RPD-renal parenchymal 
disease . 
 
 
 
 
 
 
 
S.NO 
 
 
 
 
NAME 
 
 
 
 
AGE 
 
 
 
 
SEX 
 
 
 
 
IP.NO 
CLI NICAL FEATURES  
 
 
 
DIET 
 
 
 
 
DRE 
 
 
 
 
COLONOSCOPY 
OTHER 
INVESTIGATIONS 
 
 
 
 
TREATMENT 
 
 
 
 
A
B
D
O
M
IN
A
L 
P
A
IN
  
C
O
N
ST
IP
A
TI
O
N
 
D
Y
SP
EP
SI
A
 
A
N
A
EM
IA
 
U
LT
R
A
SO
U
N
D
 
A
B
D
O
M
EN
 
O
G
D
 S
C
O
P
Y
 
31 Gandhi 50 M 43271 + - + - NV N N N APD Anti ulcer 
drugs 
32 Siluvainathn 52 M 53462 - - - + NV N N N N conservative 
33 Bakya 55 F 35621 - - + - VEG N N N N conservative 
34 Sundharam 62 M 56342 + + - - NV N N Renal 
calculi 
N conservative 
35 tamilarasan 51 M 23451 + - - + NV N haemorrhoids N N surgery 
36 Raevathi 52 F 36542 + - + - NV N N N N conservative 
37 Kabala 56 M 65473 + - + - NV N N N N conservative 
38 Pitchai 50 M 56342 + - - + NV N N N N conservative 
39 sugaanya 52 F 55435 - - + - NV N haemorrhoids N N conservative 
40 Rengarai 53 M 56321 _ + - - VEG N N Renal 
calclai 
N conservative 
               
